US20080139909A1 - Sensor with conductor and sealing glass - Google Patents
Sensor with conductor and sealing glass Download PDFInfo
- Publication number
- US20080139909A1 US20080139909A1 US12/027,902 US2790208A US2008139909A1 US 20080139909 A1 US20080139909 A1 US 20080139909A1 US 2790208 A US2790208 A US 2790208A US 2008139909 A1 US2008139909 A1 US 2008139909A1
- Authority
- US
- United States
- Prior art keywords
- probe
- cannula
- electrode
- conductor
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000004020 conductor Substances 0.000 title claims description 56
- 239000005394 sealing glass Substances 0.000 title claims description 16
- 239000000523 sample Substances 0.000 claims abstract description 213
- 239000008280 blood Substances 0.000 claims abstract description 98
- 210000004369 blood Anatomy 0.000 claims abstract description 98
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 93
- 239000001301 oxygen Substances 0.000 claims description 91
- 229910052760 oxygen Inorganic materials 0.000 claims description 91
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 90
- 239000007789 gas Substances 0.000 claims description 56
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 47
- 239000001569 carbon dioxide Substances 0.000 claims description 45
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 42
- 239000008151 electrolyte solution Substances 0.000 claims description 34
- 239000000463 material Substances 0.000 claims description 15
- 229910052697 platinum Inorganic materials 0.000 claims description 15
- 239000000853 adhesive Substances 0.000 claims description 13
- 230000001070 adhesive effect Effects 0.000 claims description 13
- 229920000306 polymethylpentene Polymers 0.000 claims description 8
- 239000011116 polymethylpentene Substances 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 238000004891 communication Methods 0.000 claims description 6
- 239000011810 insulating material Substances 0.000 claims description 5
- 238000004381 surface treatment Methods 0.000 abstract description 22
- 239000012503 blood component Substances 0.000 abstract description 8
- 230000002965 anti-thrombogenic effect Effects 0.000 abstract description 5
- 210000003414 extremity Anatomy 0.000 description 38
- 238000000034 method Methods 0.000 description 34
- 229940021013 electrolyte solution Drugs 0.000 description 24
- 239000012528 membrane Substances 0.000 description 22
- 230000004044 response Effects 0.000 description 17
- 230000000747 cardiac effect Effects 0.000 description 16
- 230000036961 partial effect Effects 0.000 description 16
- 210000004204 blood vessel Anatomy 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000004642 Polyimide Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 229920001721 polyimide Polymers 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 230000003750 conditioning effect Effects 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 210000000707 wrist Anatomy 0.000 description 9
- 229910021607 Silver chloride Inorganic materials 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 230000035699 permeability Effects 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000005286 illumination Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 210000000245 forearm Anatomy 0.000 description 6
- 230000013011 mating Effects 0.000 description 6
- 238000001139 pH measurement Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 230000004323 axial length Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 238000009413 insulation Methods 0.000 description 4
- 230000036284 oxygen consumption Effects 0.000 description 4
- 238000005476 soldering Methods 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 3
- 239000012965 benzophenone Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 210000001147 pulmonary artery Anatomy 0.000 description 3
- 210000005245 right atrium Anatomy 0.000 description 3
- 230000001235 sensitizing effect Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- -1 Polytetrafluoroethylene Polymers 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000012623 in vivo measurement Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000002106 pulse oximetry Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 229910001006 Constantan Inorganic materials 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000003126 arrythmogenic effect Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 238000010559 graft polymerization reaction Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 210000001644 umbilical artery Anatomy 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 239000013026 undiluted sample Substances 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000005019 vapor deposition process Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/22—Arrangements of medical sensors with cables or leads; Connectors or couplings specifically adapted for medical sensors
- A61B2562/225—Connectors or couplings
- A61B2562/227—Sensors with electrical connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
Definitions
- This invention relates to an apparatus for measuring physiological parameters in an individual and, in particular, to an apparatus and method for measurement of blood gas parameters of a patient.
- cardiac output measurements have been made using pulmonary artery thermodilution catheters, which can have inaccuracies of 20% or greater. It has been found that the use of such thermodilution catheters increases hospital costs while exposing the patient to potential infectious, arrhythmogenic, mechanical, and therapeutic misadventure. Blood gas measurements have also heretofore been made. Commonly used blood gas measurement techniques require a blood sample to be removed from the patient and transported to a lab analyzer for analysis. The caregiver must then wait for the results to be reported by the lab, a delay of 20 minutes being typical and longer waits not unusual.
- point-of-care blood testing systems wherein testing of blood samples is performed at a patient's bedside or in the area where the patient is located.
- Such systems include portable and handheld units and modular units which fit into a bedside monitor. While most point-of-care systems require the removal of blood from the patient for bedside analysis, a few do not.
- intermittent blood gas measurements are made by drawing a sufficiently large blood sample into an arterial line to ensure an undiluted sample at a sensor located in the line. After analysis, the blood is returned to the patient, the line is flushed, and results appear on the bedside monitor.
- pulse oximetry A non-invasive technology, pulse oximetry, is available for estimating the percentage of hemoglobin in arterial blood that is saturated with oxygen.
- pulse oximeters are capable of estimating arterial blood oxygen content, they are not capable of measuring carbon dioxide, pH, or venous oxygen content.
- ex vivo pulse oximetry is commonly performed at the fingertip and can be skewed by peripheral vasoconstriction or even nail polish.
- Coatings and their applications to medical devices have heretofore been described. See, for example, U.S. Pat. Nos. 3,443,869, 4,673,584, 5,997,517 and 5,662,960. Coatings have been employed to maintain lubricity while minimizing complications arising from use of exogenous material in vivo. Certain coatings require reapplication to maintain lubricity and certain lubricious coatings require administration of heparinized saline to maximize immunological tolerance. For devices such as catheters and probes, extraction from a physiological environment for reapplication of a lubricant increases operational costs as well as exposing the patient to heightened risk of mechanical and therapeutic misadventure. Furthermore, reapplication of a coating can compromise the gas permeability of the membrane upon which the coating is applied.
- the apparatus includes a display module and a probe having a distal extremity adapted to be inserted into the vessel of the patient and having a proximal extremity coupled to the display module.
- the probe includes a sensor in the distal extremity for providing an electrical signal to the display module when the probe is disposed in the blood.
- the probe can have an antithrombogenic surface treatment for inhibiting the adhesion of blood components to the probe when disposed in the blood.
- FIG. 1 is an isometric view of an example of an apparatus according to the present invention having a display module and a probe for monitoring physiological parameters.
- FIG. 2 is an isometric view of the probe of FIG. 1 .
- FIG. 3 is an enlarged cross-sectional view of the probe of FIG. 1 adapted for multi-parameter measurement.
- FIG. 4 is an enlarged cross-sectional view of the carbon dioxide sensor section of the probe of FIG. 1 .
- FIG. 5 is an enlarged cross-sectional view of the oxygen sensor section of the probe of FIG. 1 .
- FIG. 6A are several views of a flexible circuit subassembly of another embodiment of the probe of FIG. 1 .
- FIG. 6B is an isometric view of the probe of FIG. 1 .
- FIG. 7 is a flowchart of the surface treatment process for the probe of FIG. 1 .
- FIG. 8 is a block diagram of the circuitry contained in the display module of FIG. 1 .
- FIG. 9 is a flowchart of the processing algorithm to translate the sensor input signals into displayable values performed by the display module of FIG. 1 .
- FIG. 10 is a plan view, partially cut away, of a kit of the present invention.
- an apparatus 10 for making intravascular measurement of physiological parameters or characteristics generally includes a display module 12 and one or more probes 18 .
- the display module 12 and probe 18 are particularly adapted for accurate and continuous in vivo measurement and display of intravascular parameters such as partial pressure of oxygen (PO 2 ), partial pressure of carbon dioxide (PCO 2 ), and pH.
- cardiac output (CO) can be calculated by combining two measurements of PO 2 obtained from a pair of probes, one disposed in an artery and the other in a vein.
- the probe 18 may include sensors for other useful blood parameters such as potassium, sodium, bilirubin, hemoglobin, glucose, pressure, etc.
- probe 18 removably connects to and communicates with display module 12 by way of first or module connector 15 and mating second or probe connector 22 located at the proximal end or extremity of probe 18 .
- probe 18 comprises a flexible elongate probe body or cannula 20 formed of a polymer or other suitable insulating material, having a substantially uniform diameter over its entire length.
- the probe body 20 supports a number of electrical contacts, and preferably at least two, comprising a low-profile electrical connector 22 , and it includes a sensor section 24 and a blunt tip 26 near the distal end or extremity of the probe 18 .
- Electrodes attached to the electrodes in the sensor section 24 of the probe 18 pass through the length of the cannula 20 , preferably through a bore or lumen provided in the tubular cannula, and attach to the connector 22 .
- the sensor section 24 of the probe 18 includes electrodes inside an electrolyte-filled chamber.
- a gas permeable window preferably covers at least a portion of the chamber.
- All of the probe elements are dimensioned to fit substantially within the diameter of the probe body 20 , having a diameter in the range from 0.010′′ to 0.035′′, but preferably a diameter of 0.020′′, such that the entire probe 18 , including the low-profile connector 22 , may be passed through the inner bore of a suitable introducer, such as a hypodermic needle, of a size suitable for accessing a blood vessel in the hand, wrist, or forearm.
- a suitable introducer such as a hypodermic needle
- a suitable hypodermic needle for this purpose could be as small as 25-gauge having an inner diameter of at least 0.010 inch, and it could be as large as 18-gauge having an inner diameter of at least 0.035 inch, with the preferred size of 20-gauge having an inner diameter of at least 0.023 inch, suitable for use with a probe body having a nominal diameter of 0.020 inch.
- the probe 18 can have a suitable length such as 25 centimeters, permitting the sensor section 24 near the distal end of the probe 18 to be inserted into a blood vessel in the hand, wrist, or forearm, while the low-profile connector 22 at the proximal end or extremity of probe 18 is connected to the display module 12 , which can be strapped to the wrist of the patient.
- the low profile connector 22 is advantageous in this application, since it permits the use of an ordinary hypodermic needle or other suitable introducer to introduce the probe 18 into the blood vessel with minimal trauma to the wall of the blood vessel.
- the probe 18 is introduced into the blood vessel by first inserting the appropriately sized hypodermic needle through the skin and into the target vessel.
- the extremely sharp tip of the hypodermic needle easily penetrates the skin, the underlying tissue, and the vessel wall, while producing minimal trauma.
- the probe 18 is inserted through the bore of the needle and advanced into the vessel.
- the blunt tip 26 and the lubricious surface treatment 38 on the probe 18 minimize the likelihood of vessel trauma as the probe 18 is advanced within the target vessel.
- the introducer needle is withdrawn from the artery and the skin, and completely removed from the probe 18 by sliding it off the proximal end of the probe 18 over the low profile connector 22 , leaving the probe 18 in place in the vessel.
- the small puncture left by the hypodermic needle quickly seals around the body of the probe 18 , thereby preventing excessive bleeding.
- the puncture site is covered with a bandage and tape to guard against infection and to anchor the probe. Any blood residue on the low profile connector 22 or the exposed portion of the probe 18 is wiped away with a moist pad or alcohol swab, and the probe connector 22 is then attached to the mating connector 15 on the display module 12 .
- a conventional probe having a standard connector, requires the use of a split introducer sheath to introduce the probe into the blood vessel.
- the split introducer sheath which is blunter and bulkier than a hypodermic needle, is much more likely to stretch or tear the vessel wall, thereby increasing the risk of complications such as bleeding or prolonged healing time.
- probe 18 has been described for use in a blood vessel, it should be appreciated that the probe can be introduced into other vessels, lumen or tissue of a body of a patient, by means of any suitable introducer, and be within the scope of the present invention.
- the probe 18 is formed from a cannula, sleeve or body 20 of a suitable polymer material, which serves the purpose of constituting a structural element of the probe 18 . All or a portion of the body 20 can also serve as a gas permeable membrane enclosing or surrounding at least the sensor chambers 41 and 51 .
- the polymer sleeve material provides strength and flexibility to serve as a structural element of the probe 18 . It also permits the passage of oxygen and carbon dioxide gases while blocking the passage of liquid water and the ions dissolved therein when serving as the gas permeable membrane.
- the sleeve 20 defines the outer surface of a major portion of the probe 18 , and the substantial majority of the sleeve 20 is preferably filled with a flexible polymer 33 such as ultraviolet-cured adhesive to provide robustness to the probe body 20 , to anchor the electrical conductors 34 and sensor electrode assemblies, and to seal the ends of the sensor chambers 41 and 51 .
- the sleeve 20 provides a substantial portion of the probe strength, particularly in the sensor segment 24 , where the sensor chambers 41 and 51 are filled with liquid, and the sleeve 20 can also form the circumferential windows 31 enclosing said sensor chambers when all or a portion of the sleeve is made from a gas permeable material.
- a preferred material for the sleeve 20 shown in FIG. 3 is plastic, preferably a polymer and more preferably polymethylpentene.
- the sleeve 20 has a wall thickness in the range from 0.001 inch to 0.003 inch and preferably 0.0015 inch.
- polymethylpentene has among the highest oxygen and carbon dioxide permeability coefficients available. In addition, it has great stiffness.
- Table 1 includes gas permeability coefficients and the stiffness-related modulus of elasticity of a representative selection of commonly-used polymer materials, showing the advantages of polymethylpentene for this application.
- a cylindrical sleeve 20 of gas permeable membrane material is particularly advantageous as the covering for the blood gas sensor chamber 41 or 51 , since it creates a complete circumferential window 31 , thereby maximizing the membrane area for a given sensor length.
- the circumferential window 31 inhibits the “wall effect” artifact seen in previous blood gas sensor probes, wherein the gas permeable membrane on the tip or one side of a blood gas sensor probe is fully or partially blocked from exposure to the blood when the probe is inadvertently positioned against a vessel wall.
- the circumferential window of the present invention precludes the possibility for a substantial portion of the membrane to be blocked by close proximity of the probe to the wall of the blood vessel.
- the flow of gas through the membrane mainly affects the response time of the sensor.
- the electrolyte or other solution inside the carbon dioxide sensor chamber eventually reaches carbon dioxide equilibrium with the surrounding blood, as long as there is a reasonable rate of diffusion through the membrane.
- the oxygen sensor relies on a continuous flow of oxygen through the membrane to be consumed at the platinum sensing electrode, therefore, any significant obstruction to the flow of oxygen to the sensing electrode can affect the accuracy of the sensor.
- the sensitivity of the oxygen sensor to the “wall effect” is minimized by making the membrane permeability so high that the reaction rate is limited primarily by the rate of consumption of oxygen at the sensing electrode, which is then determined by the exposed area of platinum catalyst. In this case, any effect on the probe due to a partial blockage of the circumferential window 31 by close proximity to the wall of a blood vessel is minimized.
- the probe body 20 supports electrical contacts 32 constituting the low-profile electrical connector 22 and it contains the electrical conductors 34 and the sensor section 24 of the probe 18 .
- the electrical contacts 32 consist of gold bands or the like, soldered or welded to the electrical conductors 34 , which are electrically coupled to the one or more sensors in the sensor section 24 of the probe by any suitable conductors so as to carry the electrical signals from multiple sensors and thus permit electrical access to the probe from outside the patient's body.
- the multiple sensors can include a carbon dioxide sensor 40 , an oxygen sensor 50 , a thermocouple 47 and a pH-sensing electrode 58 , or any combination thereof or other sensors.
- a surface treatment 38 to inhibit the accumulation of thrombus, protein, or other blood components which might otherwise impair the blood flow in the vessel or impede the diffusion of oxygen or carbon dioxide into the sensing chambers 41 and 51 .
- FIG. 4 provides a detailed view of one embodiment of the carbon dioxide sensor 40 contained within the sensor section 24 of probe 18 .
- the carbon dioxide sensor 40 includes a chamber 41 containing an electrolyte solution and first and second electrodes 43 and 44 .
- the sleeve 20 and the ultraviolet-cured adhesive 33 which seals each end of the chamber 41 , define the chamber volume.
- the chamber 41 is preferably filled with an electrolyte solution such as 0.154 Molar NaCl (normal saline) with 0.001 Molar NaHCO 3 (sodium bicarbonate).
- 0.154 Molar NaCl normal saline
- NaHCO 3 sodium bicarbonate
- the reference electrode 43 for the carbon dioxide sensor preferably can be formed from a silver wire coated with silver chloride, produced by dipping a silver wire into molten silver chloride, or alternatively by a known electrochemical process.
- the sensing electrode 44 for the carbon dioxide sensor is a platinum wire coated with platinum dioxide, produced by sintering platinum dioxide powder onto the surface of a platinum wire, or alternatively, by an electrochemical or vapor deposition process.
- the electrodes 43 and 44 are attached or otherwise coupled to respective first and second electrical conductors 45 or 46 , such as insulated copper wires, by soldering or welding.
- the carbon dioxide sensor 40 occupies a small axial length of the probe 18 in the range of 1 mm to 10 mm, but preferably 4 mm, so that the sensor section 24 of the probe 18 is short enough, such as less than 20 mm, but preferably less than 13 mm, to be easily advanced into a tortuous vessel. While occupying a small axial length of the probe 18 , the carbon dioxide sensor design provides large electrode areas and maintains a large physical separation between the electrodes. Additionally, the carbon dioxide sensor provides a conduit for passage of the electrical conductors to the more distal electrodes of a multi-sensor probe, electrically isolated from the electrolyte solution inside the carbon dioxide sensor chamber 41 . In the embodiment shown in FIG.
- both the reference electrode 43 and the sensing electrode 44 are coiled around a tube 42 , such as a polyimide tube having an outer diameter of 0.011 inch, an inner diameter of 0.009 inch, and a length of 8 mm.
- the coiled electrodes 43 and 44 provide large electrode surface areas in a small volume, and the two electrodes 43 and 44 are physically separated from each other by coiling the reference electrode 43 around the proximal half of the tube 42 , while the sensing electrode 44 is coiled around the distal half of the tube 42 with a relatively large axial separation, such as 1 mm, between the two coils.
- the inner lumen of the polyimide tube 42 provides a conduit for passage of the conductors for the more distal electrodes, electrically and physically isolated from the electrolyte solution in the sensor chamber 41 by multiple layers of insulation including the insulation on the electrical conductors themselves, the polyimide tubing, and the air or adhesive that fills the inner lumen of the polyimide tube 42 .
- the polyimide tube 42 is anchored in the adhesive 33 , which seals the ends of the sensor chamber 41 , thereby providing additional mechanical strength to the carbon dioxide sensor section of the probe 18 , beyond that provided by the sleeve 20 alone.
- the electrolyte solution of the carbon dioxide sensor 40 is contained in the annular space between the polyimide tube 42 and the sleeve or body 20 of the probe 18 .
- the sleeve 20 can form a large surface area circumferential window 31 for the carbon dioxide sensor 40 , which is not easily blocked by close proximity to a blood vessel wall.
- FIG. 4 also shows a temperature sensing thermocouple 47 contained within the sensor section 24 of probe 18 .
- the thermocouple 47 can include a pair of conductors 48 and 49 of dissimilar materials, electrically connected to each other by soldering or welding.
- the conductors are chosen from known pairs of materials, such as copper and constantan, with known responses to temperature.
- the thermocouple junction is electrically insulated from the other sensor electrodes, and it is embedded within the sensor section 24 of probe 18 in proximity to the other sensors where it will accurately reflect the temperature of the surrounding blood.
- FIG. 5 provides a detailed view of one embodiment of the oxygen sensor 50 , which is contained within the sensor section 24 of probe 18 .
- the oxygen sensor 50 can include a chamber 51 containing an electrolyte solution and third and fourth electrodes 53 and 54 .
- the chamber 51 is defined by the sleeve 20 and ultraviolet-cured adhesive 33 , which seals each end of the chamber.
- the chamber is preferably filled with an electrolyte solution, such as 0.154 Molar NaCl (normal saline) buffered with 0.120 Molar NaHCO 3 (sodium bicarbonate).
- a platinum electrode 54 serves as the catalyst for a chemical reaction that consumes oxygen and generates an electrical current in proportion to the rate of consumption of oxygen at the platinum electrode, which is in turn dependent on the partial pressure of oxygen in the blood surrounding the sensor 50 .
- the sodium bicarbonate buffer stabilizes the pH of the electrolyte solution against changes that would be otherwise induced by the chemical reaction that consumes oxygen at the platinum electrode 54 .
- Probe 18 therefore advantageously provides a sufficiently large chamber volume filled with buffered electrolyte to provide the required lifetime for the oxygen sensor.
- the reference electrode 53 for the oxygen sensor 50 preferably consists of a silver wire coated with silver chloride, produced by dipping a silver wire into molten silver chloride, or alternatively by a known electrochemical process.
- the sensing electrode 54 for the oxygen sensor 50 is a platinum wire.
- the electrodes are attached or otherwise coupled to respective third and fourth electrical conductors 55 or 56 , such as insulated copper wires, by soldering or welding.
- the oxygen sensor 50 occupies a small axial length of the probe F 18 in the range of 1 mm to 10 mm, but preferably 4 mm, so that the sensor section 24 of the probe 18 is short enough, such as less than 20 mm, but preferably less than 13 mm, to be easily advanced into a tortuous artery. While occupying a small axial length of the probe 18 , the oxygen sensor design should provide a large reference electrode area, maintain a large physical separation between the electrodes, and provide a large volume of electrolyte solution. Additionally, the sensing electrode 54 exposes only a small and well-defined surface area to the electrolyte solution.
- the oxygen sensor provides a conduit for passage of the electrical conductors to the more distal electrodes of a multi-sensor probe, electrically isolated from the electrolyte solution inside the oxygen sensor chamber 51 .
- the reference electrode 53 is coiled around a tube 52 , such as a polyimide tube having an outer diameter of 0.007 inch, an inner diameter of 0.005 inch, and a length of 5 mm.
- the coiled reference electrode 53 provides a large electrode surface area in a small volume.
- the sensing electrode 54 is preferably formed from a short exposed length of a small diameter platinum wire, in the range from 0.001 inch to 0.008 inch, but preferably 0.002 inch in diameter.
- the sensing electrode 54 is formed by first oxidizing the surface of a small diameter platinum wire by heating in a furnace with an oxygen atmosphere, then fusing a bead 57 of sealing glass onto the platinum wire.
- the sealing glass is chosen to provide a coefficient of thermal expansion in the range from 8.0 to 9.2 ⁇ 10 ⁇ 6 /° K, but preferably 8.6 ⁇ 10 ⁇ 6 /° K, closely approximating or matched to the coefficient of thermal expansion for platinum, 9.0 ⁇ 10 ⁇ 6 /° K.
- the glass forms a strong bond to the platinum oxide on the surface of the platinum wire, and the matched thermal expansion coefficients minimize the thermal stress during cooling of the glass and platinum, thereby inhibiting cracking of the glass or separation of the glass from the electrode that could lead to drift in the oxygen sensor as the exposed platinum electrode area changes.
- the glass bead 57 forms a reliable seal to the platinum wire electrode 54 , ensuring a stable platinum electrode area for drift-free operation of the device.
- the bond between the sealing glass and the oxidized platinum wire is much more tenacious and fluid-resistant than the bond formed by an adhesive used in prior oxygen sensor designs, rendering the present invention much more stable than a design based on an adhesive seal.
- the oxygen sensor 50 includes a conduit 59 A, preferably formed from polyimide or other insulating tubing, for passage of the conductor 59 leading to the more distal pH-sensing electrode 58 .
- the conductor 59 is electrically and physically isolated from the electrolyte solution in the sensor chamber 51 by multiple layers of insulation including the insulation on the electrical conductor 59 , the insulating tubing conduit 59 A, and the air or adhesive that fills the inner lumen of the conduit 59 A.
- the electrolyte solution of the oxygen sensor 50 is contained in the annular space between the polyimide tube 52 and the sleeve 20 , and in the cylindrical space beyond the tip of the glass bead 57 and the platinum sensing electrode 54 .
- the sleeve 20 preferably forms a large surface area circumferential window 31 for the oxygen sensor 50 , which is not easily blocked by close proximity to a blood vessel wall.
- FIG. 5 also shows a detailed view of the pH sensor contained within the sensor section 24 of probe 18 .
- the pH sensor includes a noble metal electrode 58 , such as a gold or platinum band, mounted on the external surface of the probe 18 where it is directly exposed to the blood, and a reference electrode 43 or 53 .
- the reference electrode for the pH sensor preferably consists of a silver wire coated with silver chloride, produced by dipping a silver wire into molten silver chloride, or alternatively by a known electrochemical process.
- the reference electrode 43 or 53 can be shared with the oxygen sensor 40 or the carbon dioxide sensor 50 .
- the pH-sensing electrode 58 is attached to an electrical conductor 59 , such as an insulated copper wire, by soldering or welding.
- the probe is generally constructed from various wires, tubes, and electrodes, inserted into a bore of a tubular sleeve 20 , which is subsequently filled with adhesive and electrolyte solutions to form the sensors.
- a flexible circuit replaces the wires, tubes, and electrodes. The flexible circuit can be mass-produced in a batch process at low cost, thereby minimizing the cost of the multi-sensor probe.
- FIG. 6A shows a flexible circuit 60 which incorporates all of the electrical elements of a multi-sensor blood gas sensor probe, including electrical contact pads 62 comprising a low profile electrical connector 22 , electrical conductors 61 , and sensing electrodes 63 through 68 of various types, all fabricated on a flexible planar substrate having three layers of circuitry separated by two layers of flexible insulating substrate such as polyimide.
- a flexible circuit can be manufactured using a known batch process wherein successive layers of conducting materials on insulating substrates are deposited by electroplating, vapor deposition, or other methods, then patterned by photolithography, laser ablation, or other methods. The patterned layers are bonded together with an insulating adhesive to complete the multi-layer flexible circuit.
- circuits are cut into narrow strips having a width such as 0.015 inch, such that the circuit can be inserted into a sleeve 20 and filled with adhesive 33 and electrolyte solutions to form the sensor chambers 41 and 51 over the electrode sections of the flexible circuit 60 .
- the flexible circuit 60 has a length, such as 25 cm, appropriate for the circuit to be situated longitudinally within the lumen of a sleeve and can have a width ranging from 0.008 inch to 0.030 inch and preferably 0.015 inch.
- the proximal end or portion of the flexible circuit 60 preferably has at least two pads 62 , and more preferably seven pads 62 , which serve as the electrical contacts 32 for a low profile electrical connector 22 .
- the connector pads 62 are plated with gold to provide reliable electrical contact with the mating connector 15 of the display module 12 .
- the contact pads are connected to traces or conductors 61 , sandwiched or disposed between first and second insulating layers 161 and 162 of the flexible circuit substrate and more specifically formed one or both of the inner surfaces 163 and 164 of respective layers 161 and 162 .
- the traces 61 are in turn connected to a plurality of pads 63 - 66 and 68 near the distal end or portion of the flexible circuit 60 , which serve as electrodes for the various sensors.
- the pads and traces of the flexible circuit 60 are primarily formed of copper, and the pads are plated with various metals including silver, platinum, and gold to create the electrodes of the various sensors.
- the pads 62 , 63 - 66 and 68 on one or both of the exposed outer surfaces 166 and 167 of the flex circuit are connected to traces 61 by feedthrough vias 69 or any other suitable means.
- the reference electrodes 63 and 65 for the oxygen, carbon dioxide, and pH sensors are preferably formed by subjecting silver-plated pads to a known electrochemical process wherein the silver is reacted with chloride ions in a solution to form a layer of silver chloride on the surface of the silver.
- the sensing electrode 64 for the carbon dioxide sensor is preferably formed by subjecting a platinum-plated pad to a known electrochemical process wherein the platinum metal is reacted in a platinum chloride solution to form a platinum dioxide layer on the surface of the platinum.
- the sensing electrode 66 for the oxygen sensor is preferably formed by masking a platinum-plated pad electrode with an insulating material to define a small exposed area of platinum metal in the range from 0.001 inch to 0.008 inch in diameter, but preferably 0.002 inch in diameter.
- the pH-sensing electrode 68 is preferably a gold-plated or platinum-plated pad, directly exposed to the blood.
- the flexible circuit 60 can further accommodate a temperature sensor in the form of a patterned thin film of known material, forming a temperature-sensitive resistor 67 on inner surface 163 of first layer 161 .
- the temperature sensor can be a diode, thermistor, or thermocouple, bonded to one of the flexible circuit substrate layers 161 and 162 .
- FIG. 6B shows the flexible circuit 60 , including various electrodes, inserted into the lumen or bore of the sleeve 20 , which is preferably sealed with adhesive 33 and filled with electrolyte solutions to form the internal chambers 41 and 51 of the carbon dioxide and oxygen sensors.
- the proximal end or portion of the flexible circuit 60 includes buried traces, which serve as electrical conductors 61 , and gold-plated pads, which serve as electrical contacts 62 for the electrical connector 22 .
- the buried traces conduct electrical signals from the sensor electrodes 63 through 68 to the electrical contacts pads 62 , which serve as a low profile electrical connector 22 that can be coupled to the mating connector 15 of the display module 12 .
- At least the portion of the polymer sleeve 20 that forms the external surface of the probe 18 is preferably provided with a durable surface treatment 38 to inhibit the accumulation of thrombus, protein, or other blood components, which might otherwise impair blood flow in the artery or impede the transport of oxygen or carbon dioxide through the circumferential window 31 into the sensing chamber 41 or 51 (see FIG. 3 ).
- One preferred method for treating the surface of the sleeve 20 is photoinduced graft polymerization with N-vinylpyrrolidone to form a dense multitude of microscopic polymerized strands of polyvinylpyrrolidone, covalently bonded to the probe outer surface.
- This surface treatment 38 is durable, due to the strong covalent bonds, which anchor the polymer strands to the underlying substrate.
- the surface treatment 38 adds only a sub-micron thickness to the probe body 20 , yet it provides a hydrophilic character to the probe surface, rendering it highly lubricious when hydrated by contact with blood or water, thereby facilitating the smooth passage of the probe 18 through the blood vessel.
- This hydrophilic surface treatment 38 also inhibits the adsorption of protein onto the surface of the underlying polymer substrate, thereby minimizing the accumulation of thrombus, protein, or other blood components on the probe 18 .
- the surface treatment 38 of the polymethylpentene sleeve 20 facilitates consistent, reliable communication of the gases in the blood, such as oxygen and carbon dioxide, through the circumferential window 31 into the oxygen and carbon dioxide sensor chambers 41 and 51 , even after prolonged residence time up to three days in the bloodstream of a patient.
- One procedure for surface treatment of the polymer sleeve material is described hereinafter and is shown as a flowchart in FIG. 7 .
- the sensitizing dilution 76 is prepared in two phases.
- a blanket of nitrogen gas is applied to a volume of acetone, preferably 90 ml of acetone, after the acetone has been purged with nitrogen gas for a duration such as five minutes.
- a mass of benzophenone preferably 1.0 g of benzophenone, is dissolved in the acetone, with additional acetone added to the solution to make up a total volume of 100 ml.
- the coating solution 79 is prepared in two phases, both of which are carried out under room light illumination.
- a blanket of nitrogen gas is applied to a volume of distilled water in a flask, preferably 80 ml of distilled water, after the distilled water has been purged with nitrogen gas for a duration such as five minutes.
- N-vinylpyrrolidone preferably 11.4 grams of N-vinylpyrrolidone
- the flask is capped and the coating solution 79 is ready for storage or application.
- a membrane tubing assembly is prepared for surface treatment in step 70 by placing a mandrel inside a polymethylpentene tube of the proper length and sealing one end of the tube.
- the membrane tubing assembly is immersed in methanol and sonicated for five minutes to thoroughly clean the outer surface, then allowed to air dry for five minutes.
- the membrane tubing assembly is dipped into a sensitizing dilution 76 of benzophenone in acetone for 30 seconds, under a nitrogen purge.
- the sensitized membrane tubing assembly is then removed and placed in a dessicator, still under red light illumination, dried for a duration such as five minutes under partial vacuum such as 28 mmHg, and stored in an amber vial with a nitrogen blanket.
- a third phase or step 73 of the surface treatment procedure performed under room light illumination, the sensitized membrane tubing assembly is dipped in a volume of the N-vinylpyrrolidone coating solution 79 , such as 30 ml of solution, that has been heated to 60° C.
- the coating is cured by exposure to ultraviolet curing lights for a period such as 90 seconds, during which time the N-vinylpyrrolidone is polymerized to form a multitude of polyvinylpyrrolidone strands, covalently bonded to the membrane tubing substrate.
- the membrane tubing assembly is rinsed with copious amounts of distilled water, then placed in a dessicator to be dried under vacuum such as 28 mmHg for a period such as two hours to complete the preparation of the surface treated membrane tubing.
- the surface treated polymethylpentene tubing may be used as the sleeve 20 in the manufacture of a complete probe assembly, which will then retain the beneficial properties of the N-vinylpyrrolidone surface treatment.
- the probe assembly 18 can be manufactured using untreated tubing, and the surface treatment can be subsequently applied to the completed probe 18 using substantially the same method as describe hereinbefore.
- the display module 12 includes a housing 17 formed of a suitable material such as plastic and which is sized so that it can be worn on the patient, such as on the patient's wrist, arm or other limb, sometimes referred to herein as the subject, with the probe(s) 18 inserted into vessel(s) in the hand, wrist, or forearm.
- the module 12 also includes a display 13 such as a liquid crystal display (LCD) for displaying measured parameters and other information, and adapted to be readily visible to the attending medical professional, sometimes referred to herein as the user.
- the display 13 may include backlighting or other features that enhance the visibility of the display.
- the band 14 attached to the housing 17 is adapted to secure the display module 12 to the subject's wrist.
- the module 12 may be attached to the subject's arm or to a location near the subject.
- the module 12 may be strapped to the subject's torso, with the probe(s) 18 inserted into umbilical vessel(s).
- the band 14 is comprised of any suitable material, such as Velcro, elastic, or the like.
- Buttons 16 or keys facilitate entry of data and permit the user to affect the display 13 and other features of the module 12 . While FIG. 1 shows three buttons, any number or type of buttons, keypads, switches or the like may be used to permit entry of parameters or commands, or to otherwise interface with the apparatus 10 .
- the module 12 may also include wireless communications capability to facilitate display of physiologic parameters on a remote monitor or computer system, and/or to facilitate the entry of patient parameters or other information into the module 12 from a remote control panel or computer system.
- the module 12 also includes one or more connectors 15 that provide physical connection and communication with one or more probes 18 .
- each connector 15 includes a receptacle adapted to receive, secure, and communicate with a corresponding connector 22 on the proximal end of the probe 18 .
- the module is designed to be low in cost so that it can be packaged together with a probe(s) 18 and accessories as a disposable kit 100 , with all of the components of the kit packaged together in a sterile pouch or other container 101 , as illustrated in FIG. 10 .
- the kit would optionally include a probe holder 102 to protect the probe from damage or degradation, a wrist band 14 or other means for attaching the display module to a patient, a needle or other introducer 103 , alcohol swabs 104 for cleaning the skin prior to cannulating the vessel and for cleaning blood or other residue from the probe connector prior to attaching the probe to the module, a bandage 105 to cover the puncture site and anchor the probe in place, and any other items that may be utilized for preparing and using the probe 18 and display module 12 .
- the display module 12 is further designed to require low power so that it can operate for the expected lifetime of the device, such as 72 hours, on battery power without the need for battery replacement or connection to an external power source.
- the probe 18 is preferably suited to be a single-use, disposable device, since it has a limited operational lifetime and is used in direct contact with the subject's blood.
- the module 12 is durable enough to be used many times, however, the advantage of a disposable module is that it eliminates the expense and the infection hazard associated with cleaning, replacing batteries, and reusing a single module for multiple patients.
- An additional advantage of a disposable module 12 packaged together with its associated probe(s) 18 is that the calibration data can be stored in the module at the time of manufacture, greatly simplifying the use of the apparatus 10 by eliminating the need for the user to enter calibration data into the module prior to using the probe 18 .
- An additional advantage of a disposable module 12 packaged together with its associated probe(s) 18 is that the calibration data stored in the module at the time of manufacture can account for all of the monitor and probe inaccuracies and artifacts in a single set of calibration coefficients, thereby avoiding the accumulation of inaccuracies that can occur with separate calibrations of the probe 18 and the module 12 .
- no user inputs at all are required, eliminating the need for buttons, keypads, switches, and the like.
- the display module 12 is automatically energized upon connection of the probe 18 to the module 12 , and all of the calibration data and other needed information is pre-programmed into the module at the time of manufacture.
- FIG. 8 One embodiment of the electronic circuitry 80 included in the display module 12 is shown in block diagram form in FIG. 8 .
- signals from the one or more sensors provided on the one or more probe(s) 18 arrive at the display module 12 via connector(s) 15 .
- the sensor signals are received by a respective plurality of analog signal conditioning circuits 82 , one for each sensor in the associated probe(s) 18 .
- the outputs from the analog signal conditioning circuits 82 are directed to a microcontroller 81 , such as the Texas Instruments MSP430F435, which includes many of the circuit elements required by the display module 12 .
- the microcontroller 81 includes an analog multiplexer and an analog-to-digital converter to digitize the analog signals from the plurality of analog signal conditioning circuits 82 , as well as analog support circuitry including a voltage reference, a temperature sensor, and power supply monitoring circuitry.
- the algorithm for processing the signals, together with the sensor and module calibration coefficients is embedded in software stored in non-volatile memory included in the microcontroller 81 .
- the microcontroller 81 further includes a central processing unit to execute the software algorithm and other peripheral functions including clock circuitry, serial and parallel input/output interfaces, timers, and the LCD driver circuitry.
- the LCD driver circuitry supplies the waveforms for the liquid crystal display 13 , and the display module 12 can also communicate with an external computer or module over a serial data link via an optional wireless interface circuit 83 or other suitable means.
- Each of the analog signal conditioning circuits 82 is adapted to the particular type of sensor to which it is connected.
- the analog signal conditioning circuit can be a current-to-voltage converter with a full-scale input current that includes the maximum full-scale current expected for the oxygen sensor, such as 100 nanoamps, and a full-scale output voltage matched to the analog-to-digital converter input range.
- the input bias current for the oxygen sensor circuit is preferably much less than the normal sensor operating current, such as an input bias current of less than 100 picoamps.
- the analog signal conditioning circuit can be a voltage amplifier with very high input impedance, such as greater than 10 12 ohms, and very low input bias and input offset currents, such as less than 100 femtoamps.
- the circuit can include a fixed gain and offset voltage chosen to translate the full-scale sensor voltage range to match the analog-todigital converter input range.
- the carbon dioxide or pH sensor circuit requirements may be satisfied by an instrumentation amplifier or by a simpler operational amplifier circuit, with the amplifier selected to provide the required low input bias and offset currents.
- the analog signal conditioning circuit can be a high gain voltage amplifier with an input voltage range of zero to 2 millivolts over the expected temperature range, and an output voltage to match the analog-to-digital converter input range.
- the amplifier is preferably chosen to provide an input offset voltage much less than the signal voltage, such as an input offset voltage of less than 10 microvolts.
- One processing algorithm 90 that can be performed by the microcontroller 81 to convert the digitized sensor signals into displayable numeric values is shown in block diagram form in FIG. 9 .
- the processing algorithm includes the steps of digitizing the sampled sensor outputs in step 91 , temporal filtering or averaging to reduce the noise from external interference or other sources in step 92 , correcting for gain or offset errors in the analog signal conditioning circuitry in step 93 , incorporating gain, offset, and linearity corrections from the sensor calibration data in step 94 , compensating for the temperature dependence of the gain, offset and linearity of the sensor according to the measured probe temperature in step 95 , and translating the value into the desired units for display on the LCD in step 96 .
- the module 12 and probe 18 are calibrated together as a single disposable apparatus, then all of the gain, offset, nonlinearity, temperature, and unit conversion factors from steps 93 , 94 , 95 , and 96 can be incorporated into a single set of calibration functions that permit the direct translation of filtered analog inputs into displayable values without the need to calculate any intermediate corrections, and without the accumulation of errors from separate calibrations of the individual components of the apparatus.
- the algorithm may include step 97 of calculating other physiologic parameters according to known formulas, possibly combining readings from multiple sensors, or combining multiple readings from a single sensor to provide additional useful information.
- An example of a calculation based on a single reading from a single sensor is the estimation of arterial or venous oxygen saturation (SaO 2 or SvO 2 ) from the corresponding measured partial pressure of oxygen (PaO 2 or PvO 2 ).
- SaO 2 or SvO 2 arterial or venous oxygen saturation
- PaO 2 or PvO 2 measured partial pressure of oxygen
- An example of a calculation based on multiple readings from a single sensor is the determination of the trend in the associated blood gas parameter, that is, whether the value is increasing, decreasing, or stable.
- the trend in the blood gas parameter can be symbolically indicated on the display, making it easier for the user to quickly assess patient status.
- An example of a calculation based on combined readings from multiple sensors on multiple probes is the use of an arterial oxygen reading and a venous oxygen reading to estimate the cardiac output using a modified version of the Fick oxygen consumption method.
- cardiac output (liters/minute) is calculated as the oxygen consumption (milliliters/minute), divided by the arteriovenous oxygen concentration difference (milliliters of O 2 per liter of blood).
- oxygen consumption is estimated as 3 milliliters/kilogram times the subject's weight, which can be entered into the module by way of the buttons or keys, or by way of a wireless communication from an external computer or control panel.
- the arteriovenous oxygen concentration difference can be calculated as the difference between the arterial oxygen saturation and the venous oxygen saturation (SaO 2 ⁇ SvO 2 ) times the standard value of 170 milliliters of O 2 per liter of blood.
- the value of the venous oxygen saturation may be adjusted to compensate for the experimentally determined discrepancy between the pulmonary artery oxygen saturation and the forearm venous oxygen saturation.
- the incorporation of wireless interface circuitry into the display module is advantageous in preserving the electrical safety and freedom of movement of the patient afforded by the self-contained, battery-powered display unit, while providing the benefits of an integrated system in terms of centralized data collection.
- the compact display module of the present invention makes the most of the wireless communications by freeing the subject from the tubes and cables that normally tether them to their bed, and by eliminating the need for additional bulky instrumentation at the already crowded bedside.
- a single probe may include more than one sensor, e.g., an oxygen sensor, a carbon dioxide sensor, a temperature sensor, and a pH sensor.
- the sensors are included in a probe body, having a small diameter of less than 0.023′′ so that it can be readily inserted through a 20-gauge needle into a blood vessel in the hand, wrist, or forearm.
- This probe includes at least one sensor with a window 31 having a large surface area and high permeability to the target gas molecules, which facilitates the rapid diffusion of blood gases into or out of the sensor chamber to ensure a fast response to changes in the blood gas concentration.
- the probes utilized are preferably blunt tipped and atraumatic to the vessel wall and are preferably provided with an antithrombogenic surface treatment to inhibit the formation of thrombus or the adhesion of protein or other blood components, ensuring consistent performance of the blood gas sensors and minimizing the need for continuous infusion of heparin to maintain a clot-free environment.
- the probe carries electrical signals from the sensors, through electrical conductors, to a low profile or other connector removably attached to a mating connector on the display module.
- the low profile of the preferred connector facilitates the removal of the hypodermic needle or other introducer used to most simply introduce the probe into the lumen of a vein or artery, thereby eliminating the need for using a split sheath introducer or other more complex technique for introducing the probe into the vessel.
- the display module is small and inexpensive, and it is particularly suited for attachment to the patient's wrist.
- the apparatus and method herein described may be adapted to the particular requirements of a variety of different medical applications, several of which are outlined below.
- ICU intensive care unit
- CCU coronary care unit
- this monitoring is performed on an intermittent basis, typically three to twelve times per day, by drawing a blood sample from an arterial line in the patient's forearm, and delivering the blood sample to a blood gas analyzer.
- a multi-sensor probe as described herein, providing continuous oxygen, carbon dioxide, and pH measurements can eliminate the need and the associated expense and risks of placing and maintaining an arterial line and repeatedly drawing blood samples therefrom.
- the continuous monitoring provided by the present invention gives rapid feedback regarding the effects of any interventions such as adjustments to the ventilator settings or administration of drugs. The timely feedback on the effects of the medical interventions permits the subject to be more quickly weaned from the ventilator and released from the ICU/CCU, a benefit to the both the patient and the healthcare system.
- thermodilution technique which requires placement of a Swan-Ganz catheter in the jugular vein, through the right atrium and right ventricle, and into a branch of the pulmonary artery.
- the thermodilution technique requires injections of cold saline boluses at intervals, whenever a cardiac output reading is desired.
- the replacement of the right heart catheter with the present invention greatly reduces the risk to the patient by eliminating the right heart catheterization procedure, and it provides greater utility by providing on demand cardiac output readings without cumbersome injections of cold saline.
- a simpler apparatus is a single venous oxygen probe used to monitor the venous oxygen content. This value is combined with independent measurements of arterial oxygen saturation from a noninvasive pulse oximeter, hemoglobin density from a daily blood sample, and calculated oxygen consumption according to the standard approximation based on weight and height, to calculate cardiac output according to the Fick method.
- the probe is placed in a vein in the hand, using an experimentally determined compensation factor to account for the expected difference between the oxygen saturation in the right atrium and the oxygen saturation in a vein of the hand.
- the oxygen probe can be inserted directly through the jugular vein in the neck, into the vena cava or the right atrium of the heart to provide a direct measurement of the oxygen saturation of the mixed venous blood without the need for a compensation factor.
- the venous oxygen content is a valuable parameter on its own for assessing the status of the patient.
- the present invention is particularly suitable for neonates, since it minimizes if not eliminates the need for drawing blood from the neonate subject with a small blood volume to draw from.
- the addition of hemoglobin, bilirubin, electrolyte, or glucose sensors to the blood gas and pH sensors increases the utility of the multi-sensor probe for this application.
- the probes are conveniently inserted into umbilical arteries and veins, and the display module is appropriate in size to be strapped around the abdomen of a neonate.
- oxygen saturation data is collected in conjunction with an angiographic study of the heart, and it permits the operation of a malformed heart to be more accurately diagnosed, thereby resulting in more appropriate treatment for the patient.
- oxygen saturation data is collected by drawing multiple blood samples through a small catheter from a variety of locations throughout the heart and the great vessels. These blood samples are sequentially transferred to a blood gas analyzer to obtain an oxygen saturation reading for each sample.
- a small oxygen sensor mounted on a probe or guidewire of suitable size such as less than 0.023′′ in diameter and 50 to 150 cm in length can be advanced through a guiding catheter to various locations in the heart and the great vessels to sample the oxygen saturation in vivo, thereby reducing the risk to the patient by eliminating the need to draw a large number of blood samples from a small subject and by reducing the time for the procedure.
- an apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood comprises a display module and a probe having a distal extremity adapted to be inserted into the vessel of the patient and having a proximal extremity coupled to the display module.
- the probe includes a gas sensor assembly mounted in the distal extremity for providing an electrical signal to the display module when the probe is disposed in the blood.
- the probe has an antithrombogenic surface treatment for inhibiting the adhesion of blood components to the probe when disposed in the blood.
- a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood comprises a cannula adapted to be inserted into the vessel of the patient and a gas sensor assembly mounted inside the cannula.
- the cannula has an antithrombogenic surface treatment for inhibiting the adhesion of blood components to the cannula when disposed in the blood.
- a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood comprises a cannula having proximal and distal extremities, the distal extremity being adapted to be inserted into the vessel of the patient.
- a gas sensor assembly is mounted inside the distal extremity of the cannula.
- the cannula has an annular window of a gas permeable material extending around the gas sensor assembly.
- the probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood.
- the probe comprises a cannula having proximal and distal extremities, the distal extremity being adapted to be inserted into the vessel of the patient.
- An electrolyte solution is disposed in the cannula.
- a gas sensor assembly is mounted in the distal extremity of the cannula and includes an electrode disposed in the electrolyte solution.
- a conductor extends to the electrode and a sealing glass extends around the conductor.
- the conductor has a coefficient of thermal expansion and the sealing glass has a coefficient of thermal expansion approximating the coefficient of thermal expansion of the conductor for inhibiting separation of the conductor from the sealing glass and thus inhibiting the electrolyte solution from creeping between the conductor and the sealing glass.
- a further aspect of the invention provides an apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood.
- the apparatus comprises a display module and a probe, the probe having proximal and distal extremities.
- the distal extremity of the probe is adapted to be inserted into the vessel of the patient and has a gas sensor assembly for providing an electrical signal when the probe is disposed in the blood.
- the display module has a first connector and the proximal extremity of the probe has a second connector for mating with the first connector.
- the second connector has a cylindrical portion and an electrical contact extending around at least a portion of the cylindrical portion.
- a conductor extends though the probe for electrically coupling the gas sensor assembly with the electrical contact.
- the electrical contact is seated flush with the cylindrical portion so as to provide the second connector with a substantially smooth cylindrical surface.
- the first and second connectors permit connection and disconnection between the probe and the display module.
- a probe for use with an introducer in a patient having a vessel carrying blood to ascertain characteristics of the blood comprises a cannula having proximal and distal extremities.
- the distal extremity of the cannula is adapted to be inserted into the vessel of the patient.
- a gas sensor assembly is disposed in the distal extremity of the cannula for providing an electrical signal when the cannula is disposed in the blood.
- a connector is provided on the proximal extremity of the cannula.
- the distal extremity of the cannula is adapted for slidable travel through the introducer when inserting the cannula into the vessel.
- the cannula and connector have a size which permits the introducer to be slid off of the proximal extremity of the cannula and the connector after the distal extremity of the cannula has been inserted into the vessel.
- An aspect of the invention also provides an apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood.
- the apparatus comprises a compact display module and a probe, the probe having a proximal extremity coupled to the display module and a distal extremity adapted to be inserted into the vessel of the patient.
- the distal extremity includes a sensor for providing an electrical signal to the display module when the probe is disposed in the blood.
- the probe has calibration coefficients.
- the display module has a processor for processing the electrical signal to provide a reading and a memory for storing the calibration coefficients.
- the processor is coupled to the memory to permit access by the processor to the calibration coefficients in connection with the processing of the electrical signal so as to enhance the accuracy of the reading.
- a kit for use with a patient having a vessel carrying blood to ascertain characteristics of the blood is provided in another aspect of the invention.
- the kit comprises a package.
- a probe is carried within the package.
- the probe has a distal extremity adapted to be inserted into the vessel of the patient and includes a sensor for providing an electrical signal.
- the probe has calibration coefficients.
- a compact display module is carried within the package and has a processor and a nonvolatile memory coupled to the processor.
- the calibration coefficients are stored in the memory of the display module.
- a further aspect of the invention provides a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood.
- the probe comprises a cannula adapted to be inserted into the vessel of the patient and having proximal and distal extremities.
- An electrolyte solution is disposed in the distal extremity of the cannula.
- a gas sensor assembly is mounted in the distal extremity of the cannula and is disposed in the electrolyte solution.
- the gas sensor assembly has a tube with a distal portion and a first electrode coiled around the tube.
- a second electrode is carried by the distal portion of the tube.
- First and second conductors extend from the proximal extremity of the cannula to the gas sensor assembly, the first conductor being coupled to the first electrode and the second conductor extending through the tube and being coupled to the second electrode.
- the tube serves as support for the first electrode and as a conduit for the second conductor.
- a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood is also provided.
- the probe comprises a cannula having proximal and distal extremities.
- the distal extremity is adapted to be inserted into the vessel of the patient.
- a flex circuit extends through at least a portion of the cannula.
- the flex circuit has proximal and distal portions with first and second electrodes formed on the distal portion and first and second conductors extending from the proximal portion to the first and second electrodes.
- An electrolyte solution is disposed in the distal extremity of the cannula in the vicinity of the first and second electrodes.
- Chart 1 shows the performance of a representative example of an oxygen sensor probe over a range of dissolved oxygen concentrations from zero to 150 mmHg partial pressure of oxygen. The response is linear over the range of interest, making the calibration to 5% accuracy a simple process.
- Chart 2 shows the time response of a representative oxygen sensor probe to a sequence of step changes in oxygen partial pressure, demonstrating a settling time of less than 3 minutes to a within 5% of the final value.
- Chart 3 shows the stability of the oxygen sensor output over the course of a 90-hour longevity study. With a constant, room air, partial pressure of oxygen of 150 mmHg, the output of the sensor remains nearly constant for greater than 72 hours except for the expected small variations in output due to temperature fluctuations and noise.
- Chart 4 shows the performance of a representative example of a carbon dioxide sensor probe over a range of dissolved carbon dioxide concentrations from 10 to 100 mmHg partial pressure of carbon dioxide.
- the response shows the classic logarithmic performance expected for this type of pH-responsive sensor, making calibration to 5% accuracy a simple process.
- the carbon dioxide sensor provides rapid response to changes in the dissolved carbon dioxide concentration.
- Chart 5 shows the time response of a representative carbon dioxide sensor probe to a sequence of step changes in carbon dioxide partial pressure, demonstrating a settling time of less than three minutes to a within 5% of the final value.
- the carbon dioxide sensor has an inherently long lifetime, since it does not consume the electrodes or the electrolyte solution as the oxygen sensor does.
- Chart 6 shows the performance of a representative pH sensor output over a range of pH from 4 to 10.
- This pH sensor is mounted in a multi-sensor probe that also includes oxygen, carbon dioxide, and temperature sensors.
- the response shows the classic linear voltage response to the logarithmic pH parameter.
- the standard deviation for repeated measurements at a single pH value is approximately 0.02 pH, demonstrating that calibration to the required 0.05 pH accuracy over the physiological range of pH from 7 to 8 is feasible.
- the response time of the pH sensor is fast, with a settling time of approximately 10 seconds to a step change in the pH value.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
An apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood. The apparatus includes a display module and a probe having a distal extremity adapted to be inserted into the vessel of the patient and having a proximal extremity coupled to the display module. The probe includes a sensor in the distal extremity for providing an electrical signal to the display module when the probe is disposed in the blood. The probe can have an antithrombogenic surface treatment for inhibiting the adhesion of blood components to the probe when disposed in the blood.
Description
- This application is a divisional of U.S. patent application Ser. No. 10/658,926, filed Sep. 9, 2003, the disclosure of which is hereby incorporated by reference in its entirety.
- 1. Field of the Invention
- This invention relates to an apparatus for measuring physiological parameters in an individual and, in particular, to an apparatus and method for measurement of blood gas parameters of a patient.
- 2. Description of the Related Art
- Determination of cardiac output, arterial blood gases, and other hemodynamic or cardiovascular parameters is critically important in the treatment and care of patients, particularly those undergoing surgery or other complicated medical procedures and those under intensive care. Typically, cardiac output measurements have been made using pulmonary artery thermodilution catheters, which can have inaccuracies of 20% or greater. It has been found that the use of such thermodilution catheters increases hospital costs while exposing the patient to potential infectious, arrhythmogenic, mechanical, and therapeutic misadventure. Blood gas measurements have also heretofore been made. Commonly used blood gas measurement techniques require a blood sample to be removed from the patient and transported to a lab analyzer for analysis. The caregiver must then wait for the results to be reported by the lab, a delay of 20 minutes being typical and longer waits not unusual.
- More recent advances in the art have provided for “point-of-care” blood testing systems wherein testing of blood samples is performed at a patient's bedside or in the area where the patient is located. Such systems include portable and handheld units and modular units which fit into a bedside monitor. While most point-of-care systems require the removal of blood from the patient for bedside analysis, a few do not. In such systems, intermittent blood gas measurements are made by drawing a sufficiently large blood sample into an arterial line to ensure an undiluted sample at a sensor located in the line. After analysis, the blood is returned to the patient, the line is flushed, and results appear on the bedside monitor.
- A non-invasive technology, pulse oximetry, is available for estimating the percentage of hemoglobin in arterial blood that is saturated with oxygen. Although pulse oximeters are capable of estimating arterial blood oxygen content, they are not capable of measuring carbon dioxide, pH, or venous oxygen content. Furthermore, ex vivo pulse oximetry is commonly performed at the fingertip and can be skewed by peripheral vasoconstriction or even nail polish.
- Unfortunately, none of the available systems or methods for blood gas analysis provide for accurate, direct and continuous in vivo measurements of arterial and venous oxygen partial pressures, carbon-dioxide partial pressure, pH, and cardiac output, while presenting minimal risk to the patient.
- Coatings and their applications to medical devices have heretofore been described. See, for example, U.S. Pat. Nos. 3,443,869, 4,673,584, 5,997,517 and 5,662,960. Coatings have been employed to maintain lubricity while minimizing complications arising from use of exogenous material in vivo. Certain coatings require reapplication to maintain lubricity and certain lubricious coatings require administration of heparinized saline to maximize immunological tolerance. For devices such as catheters and probes, extraction from a physiological environment for reapplication of a lubricant increases operational costs as well as exposing the patient to heightened risk of mechanical and therapeutic misadventure. Furthermore, reapplication of a coating can compromise the gas permeability of the membrane upon which the coating is applied.
- An apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood is provided. The apparatus includes a display module and a probe having a distal extremity adapted to be inserted into the vessel of the patient and having a proximal extremity coupled to the display module. The probe includes a sensor in the distal extremity for providing an electrical signal to the display module when the probe is disposed in the blood. The probe can have an antithrombogenic surface treatment for inhibiting the adhesion of blood components to the probe when disposed in the blood.
- For a better understanding of the nature and details of the invention, reference should be made to the following drawings, which in some instances are schematic in detail and wherein like reference numerals have been used throughout.
-
FIG. 1 is an isometric view of an example of an apparatus according to the present invention having a display module and a probe for monitoring physiological parameters. -
FIG. 2 is an isometric view of the probe ofFIG. 1 . -
FIG. 3 is an enlarged cross-sectional view of the probe ofFIG. 1 adapted for multi-parameter measurement. -
FIG. 4 is an enlarged cross-sectional view of the carbon dioxide sensor section of the probe ofFIG. 1 . -
FIG. 5 is an enlarged cross-sectional view of the oxygen sensor section of the probe ofFIG. 1 . -
FIG. 6A are several views of a flexible circuit subassembly of another embodiment of the probe ofFIG. 1 . -
FIG. 6B is an isometric view of the probe ofFIG. 1 . -
FIG. 7 is a flowchart of the surface treatment process for the probe ofFIG. 1 . -
FIG. 8 is a block diagram of the circuitry contained in the display module ofFIG. 1 . -
FIG. 9 is a flowchart of the processing algorithm to translate the sensor input signals into displayable values performed by the display module ofFIG. 1 . -
FIG. 10 is a plan view, partially cut away, of a kit of the present invention. - Like reference numerals refer to corresponding parts throughout the several views of the drawings.
- Referring to
FIG. 1 , anapparatus 10 according to the present invention for making intravascular measurement of physiological parameters or characteristics generally includes adisplay module 12 and one ormore probes 18. As described in more detail herein, thedisplay module 12 andprobe 18 are particularly adapted for accurate and continuous in vivo measurement and display of intravascular parameters such as partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2), and pH. In addition, cardiac output (CO) can be calculated by combining two measurements of PO2 obtained from a pair of probes, one disposed in an artery and the other in a vein. Alternatively, or in addition to the aforementioned sensors, theprobe 18 may include sensors for other useful blood parameters such as potassium, sodium, bilirubin, hemoglobin, glucose, pressure, etc. Additional features of thedisplay module 12 andprobe 18 are detailed hereinafter and in copending U.S. patent application Ser. No. 09/956,064 filed Sep. 18, 2001 and now U.S. Pat. No. 6,616,614, the entire content of which is incorporated herein by this reference. - As described herein,
probe 18 removably connects to and communicates withdisplay module 12 by way of first ormodule connector 15 and mating second orprobe connector 22 located at the proximal end or extremity ofprobe 18. Preferably, as shown inFIG. 2 ,probe 18 comprises a flexible elongate probe body orcannula 20 formed of a polymer or other suitable insulating material, having a substantially uniform diameter over its entire length. Theprobe body 20 supports a number of electrical contacts, and preferably at least two, comprising a low-profileelectrical connector 22, and it includes asensor section 24 and ablunt tip 26 near the distal end or extremity of theprobe 18. Electrical conductors attached to the electrodes in thesensor section 24 of theprobe 18 pass through the length of thecannula 20, preferably through a bore or lumen provided in the tubular cannula, and attach to theconnector 22. Thesensor section 24 of theprobe 18 includes electrodes inside an electrolyte-filled chamber. A gas permeable window preferably covers at least a portion of the chamber. All of the probe elements are dimensioned to fit substantially within the diameter of theprobe body 20, having a diameter in the range from 0.010″ to 0.035″, but preferably a diameter of 0.020″, such that theentire probe 18, including the low-profile connector 22, may be passed through the inner bore of a suitable introducer, such as a hypodermic needle, of a size suitable for accessing a blood vessel in the hand, wrist, or forearm. Depending on the diameter of theprobe body 20, a suitable hypodermic needle for this purpose could be as small as 25-gauge having an inner diameter of at least 0.010 inch, and it could be as large as 18-gauge having an inner diameter of at least 0.035 inch, with the preferred size of 20-gauge having an inner diameter of at least 0.023 inch, suitable for use with a probe body having a nominal diameter of 0.020 inch. In this preferred embodiment, theprobe 18 can have a suitable length such as 25 centimeters, permitting thesensor section 24 near the distal end of theprobe 18 to be inserted into a blood vessel in the hand, wrist, or forearm, while the low-profile connector 22 at the proximal end or extremity ofprobe 18 is connected to thedisplay module 12, which can be strapped to the wrist of the patient. - The
low profile connector 22 is advantageous in this application, since it permits the use of an ordinary hypodermic needle or other suitable introducer to introduce theprobe 18 into the blood vessel with minimal trauma to the wall of the blood vessel. Theprobe 18 is introduced into the blood vessel by first inserting the appropriately sized hypodermic needle through the skin and into the target vessel. The extremely sharp tip of the hypodermic needle easily penetrates the skin, the underlying tissue, and the vessel wall, while producing minimal trauma. Once the hypodermic introducer needle has entered the target blood vessel, theprobe 18 is inserted through the bore of the needle and advanced into the vessel. Theblunt tip 26 and thelubricious surface treatment 38 on theprobe 18 minimize the likelihood of vessel trauma as theprobe 18 is advanced within the target vessel. Once theprobe 18 is properly positioned within the target vessel, the introducer needle is withdrawn from the artery and the skin, and completely removed from theprobe 18 by sliding it off the proximal end of theprobe 18 over thelow profile connector 22, leaving theprobe 18 in place in the vessel. The small puncture left by the hypodermic needle quickly seals around the body of theprobe 18, thereby preventing excessive bleeding. The puncture site is covered with a bandage and tape to guard against infection and to anchor the probe. Any blood residue on thelow profile connector 22 or the exposed portion of theprobe 18 is wiped away with a moist pad or alcohol swab, and theprobe connector 22 is then attached to themating connector 15 on thedisplay module 12. In contrast to the simple, minimally traumatic introduction method facilitated by the low-profile connector, a conventional probe, having a standard connector, requires the use of a split introducer sheath to introduce the probe into the blood vessel. The split introducer sheath, which is blunter and bulkier than a hypodermic needle, is much more likely to stretch or tear the vessel wall, thereby increasing the risk of complications such as bleeding or prolonged healing time. Althoughprobe 18 has been described for use in a blood vessel, it should be appreciated that the probe can be introduced into other vessels, lumen or tissue of a body of a patient, by means of any suitable introducer, and be within the scope of the present invention. - In a preferred embodiment, illustrated in
FIG. 3 , theprobe 18 is formed from a cannula, sleeve orbody 20 of a suitable polymer material, which serves the purpose of constituting a structural element of theprobe 18. All or a portion of thebody 20 can also serve as a gas permeable membrane enclosing or surrounding at least thesensor chambers probe 18. It also permits the passage of oxygen and carbon dioxide gases while blocking the passage of liquid water and the ions dissolved therein when serving as the gas permeable membrane. Thesleeve 20 defines the outer surface of a major portion of theprobe 18, and the substantial majority of thesleeve 20 is preferably filled with aflexible polymer 33 such as ultraviolet-cured adhesive to provide robustness to theprobe body 20, to anchor theelectrical conductors 34 and sensor electrode assemblies, and to seal the ends of thesensor chambers sleeve 20 provides a substantial portion of the probe strength, particularly in thesensor segment 24, where thesensor chambers sleeve 20 can also form thecircumferential windows 31 enclosing said sensor chambers when all or a portion of the sleeve is made from a gas permeable material. - A preferred material for the
sleeve 20 shown inFIG. 3 is plastic, preferably a polymer and more preferably polymethylpentene. Thesleeve 20 has a wall thickness in the range from 0.001 inch to 0.003 inch and preferably 0.0015 inch. Among commonly-used polymers suitable for extrusion as thin-walled tubing, polymethylpentene has among the highest oxygen and carbon dioxide permeability coefficients available. In addition, it has great stiffness. Table 1 includes gas permeability coefficients and the stiffness-related modulus of elasticity of a representative selection of commonly-used polymer materials, showing the advantages of polymethylpentene for this application. -
CO2 Tensile permeability 02 permeability Modulus Material (Barrer1) (Barrer1) (GPa) Polymethylpentene 80 27 1.5 _Low Density Polyethylene 13 10 0.1-0.3 Polytetrafluoroethylene 10 4.3 0.3-0.8 Polypropylene 8 2.3 0.9-1.5 Polycarbonate 6.4 1.4 2.3-2.4 Polyimide 0.3 0.15 2-3 Polyester 0.13 0.05 2-4 Nylon 0.09 0.04 2.6-3.0 1The Barrer is a unit of gas permeability, equivalent to 10−10 (cm3 per second of gas at standard temperature and pressure) (cm of membrane thickness) per (cm2 of membrane area) per (cmHg of pressure) - A
cylindrical sleeve 20 of gas permeable membrane material is particularly advantageous as the covering for the bloodgas sensor chamber circumferential window 31, thereby maximizing the membrane area for a given sensor length. In addition to maximizing the membrane area, thecircumferential window 31 inhibits the “wall effect” artifact seen in previous blood gas sensor probes, wherein the gas permeable membrane on the tip or one side of a blood gas sensor probe is fully or partially blocked from exposure to the blood when the probe is inadvertently positioned against a vessel wall. The circumferential window of the present invention precludes the possibility for a substantial portion of the membrane to be blocked by close proximity of the probe to the wall of the blood vessel. For the carbon dioxide sensor, the flow of gas through the membrane mainly affects the response time of the sensor. The electrolyte or other solution inside the carbon dioxide sensor chamber eventually reaches carbon dioxide equilibrium with the surrounding blood, as long as there is a reasonable rate of diffusion through the membrane. However, the oxygen sensor relies on a continuous flow of oxygen through the membrane to be consumed at the platinum sensing electrode, therefore, any significant obstruction to the flow of oxygen to the sensing electrode can affect the accuracy of the sensor. The sensitivity of the oxygen sensor to the “wall effect” is minimized by making the membrane permeability so high that the reaction rate is limited primarily by the rate of consumption of oxygen at the sensing electrode, which is then determined by the exposed area of platinum catalyst. In this case, any effect on the probe due to a partial blockage of thecircumferential window 31 by close proximity to the wall of a blood vessel is minimized. - The
probe body 20 supportselectrical contacts 32 constituting the low-profileelectrical connector 22 and it contains theelectrical conductors 34 and thesensor section 24 of theprobe 18. Theelectrical contacts 32 consist of gold bands or the like, soldered or welded to theelectrical conductors 34, which are electrically coupled to the one or more sensors in thesensor section 24 of the probe by any suitable conductors so as to carry the electrical signals from multiple sensors and thus permit electrical access to the probe from outside the patient's body. The multiple sensors can include acarbon dioxide sensor 40, anoxygen sensor 50, athermocouple 47 and a pH-sensingelectrode 58, or any combination thereof or other sensors. Preferably, at least the portion of thesleeve 20 that is placed inside the blood vessel, including thesensor section 24, is provided with asurface treatment 38 to inhibit the accumulation of thrombus, protein, or other blood components which might otherwise impair the blood flow in the vessel or impede the diffusion of oxygen or carbon dioxide into thesensing chambers -
FIG. 4 provides a detailed view of one embodiment of thecarbon dioxide sensor 40 contained within thesensor section 24 ofprobe 18. Thecarbon dioxide sensor 40 includes achamber 41 containing an electrolyte solution and first andsecond electrodes sleeve 20 and the ultraviolet-curedadhesive 33, which seals each end of thechamber 41, define the chamber volume. Thechamber 41 is preferably filled with an electrolyte solution such as 0.154 Molar NaCl (normal saline) with 0.001 Molar NaHCO3 (sodium bicarbonate). The pH of this solution varies with the partial pressure of carbon dioxide, and theelectrodes reference electrode 43 for the carbon dioxide sensor preferably can be formed from a silver wire coated with silver chloride, produced by dipping a silver wire into molten silver chloride, or alternatively by a known electrochemical process. Thesensing electrode 44 for the carbon dioxide sensor is a platinum wire coated with platinum dioxide, produced by sintering platinum dioxide powder onto the surface of a platinum wire, or alternatively, by an electrochemical or vapor deposition process. Theelectrodes electrical conductors - Ideally, the
carbon dioxide sensor 40 occupies a small axial length of theprobe 18 in the range of 1 mm to 10 mm, but preferably 4 mm, so that thesensor section 24 of theprobe 18 is short enough, such as less than 20 mm, but preferably less than 13 mm, to be easily advanced into a tortuous vessel. While occupying a small axial length of theprobe 18, the carbon dioxide sensor design provides large electrode areas and maintains a large physical separation between the electrodes. Additionally, the carbon dioxide sensor provides a conduit for passage of the electrical conductors to the more distal electrodes of a multi-sensor probe, electrically isolated from the electrolyte solution inside the carbondioxide sensor chamber 41. In the embodiment shown inFIG. 4 , both thereference electrode 43 and thesensing electrode 44 are coiled around atube 42, such as a polyimide tube having an outer diameter of 0.011 inch, an inner diameter of 0.009 inch, and a length of 8 mm. Thecoiled electrodes electrodes reference electrode 43 around the proximal half of thetube 42, while thesensing electrode 44 is coiled around the distal half of thetube 42 with a relatively large axial separation, such as 1 mm, between the two coils. Additionally, the inner lumen of thepolyimide tube 42 provides a conduit for passage of the conductors for the more distal electrodes, electrically and physically isolated from the electrolyte solution in thesensor chamber 41 by multiple layers of insulation including the insulation on the electrical conductors themselves, the polyimide tubing, and the air or adhesive that fills the inner lumen of thepolyimide tube 42. Thepolyimide tube 42 is anchored in the adhesive 33, which seals the ends of thesensor chamber 41, thereby providing additional mechanical strength to the carbon dioxide sensor section of theprobe 18, beyond that provided by thesleeve 20 alone. The electrolyte solution of thecarbon dioxide sensor 40 is contained in the annular space between thepolyimide tube 42 and the sleeve orbody 20 of theprobe 18. Thesleeve 20 can form a large surface areacircumferential window 31 for thecarbon dioxide sensor 40, which is not easily blocked by close proximity to a blood vessel wall. -
FIG. 4 also shows atemperature sensing thermocouple 47 contained within thesensor section 24 ofprobe 18. Thethermocouple 47 can include a pair ofconductors sensor section 24 ofprobe 18 in proximity to the other sensors where it will accurately reflect the temperature of the surrounding blood. -
FIG. 5 provides a detailed view of one embodiment of theoxygen sensor 50, which is contained within thesensor section 24 ofprobe 18. Theoxygen sensor 50 can include achamber 51 containing an electrolyte solution and third andfourth electrodes chamber 51 is defined by thesleeve 20 and ultraviolet-curedadhesive 33, which seals each end of the chamber. The chamber is preferably filled with an electrolyte solution, such as 0.154 Molar NaCl (normal saline) buffered with 0.120 Molar NaHCO3 (sodium bicarbonate). With an appropriate electrical potential biasing the electrodes, such as 0.70 volts, aplatinum electrode 54 serves as the catalyst for a chemical reaction that consumes oxygen and generates an electrical current in proportion to the rate of consumption of oxygen at the platinum electrode, which is in turn dependent on the partial pressure of oxygen in the blood surrounding thesensor 50. The sodium bicarbonate buffer stabilizes the pH of the electrolyte solution against changes that would be otherwise induced by the chemical reaction that consumes oxygen at theplatinum electrode 54. When the buffer or electrolyte solution is exhausted, or when thesensor chamber 51 becomes filled with excessive silver chloride precipitate, the oxygen sensor response will change, and the sensor will no longer be viable.Probe 18 therefore advantageously provides a sufficiently large chamber volume filled with buffered electrolyte to provide the required lifetime for the oxygen sensor. Thereference electrode 53 for theoxygen sensor 50 preferably consists of a silver wire coated with silver chloride, produced by dipping a silver wire into molten silver chloride, or alternatively by a known electrochemical process. Thesensing electrode 54 for theoxygen sensor 50 is a platinum wire. The electrodes are attached or otherwise coupled to respective third and fourthelectrical conductors - Preferably, the
oxygen sensor 50 occupies a small axial length of theprobe F 18 in the range of 1 mm to 10 mm, but preferably 4 mm, so that thesensor section 24 of theprobe 18 is short enough, such as less than 20 mm, but preferably less than 13 mm, to be easily advanced into a tortuous artery. While occupying a small axial length of theprobe 18, the oxygen sensor design should provide a large reference electrode area, maintain a large physical separation between the electrodes, and provide a large volume of electrolyte solution. Additionally, thesensing electrode 54 exposes only a small and well-defined surface area to the electrolyte solution. Additionally, the oxygen sensor provides a conduit for passage of the electrical conductors to the more distal electrodes of a multi-sensor probe, electrically isolated from the electrolyte solution inside theoxygen sensor chamber 51. In the embodiment shown inFIG. 5 , thereference electrode 53 is coiled around atube 52, such as a polyimide tube having an outer diameter of 0.007 inch, an inner diameter of 0.005 inch, and a length of 5 mm. Thecoiled reference electrode 53 provides a large electrode surface area in a small volume. Thesensing electrode 54 is preferably formed from a short exposed length of a small diameter platinum wire, in the range from 0.001 inch to 0.008 inch, but preferably 0.002 inch in diameter. - Preferably, the
sensing electrode 54 is formed by first oxidizing the surface of a small diameter platinum wire by heating in a furnace with an oxygen atmosphere, then fusing abead 57 of sealing glass onto the platinum wire. The sealing glass is chosen to provide a coefficient of thermal expansion in the range from 8.0 to 9.2×10−6/° K, but preferably 8.6×10−6/° K, closely approximating or matched to the coefficient of thermal expansion for platinum, 9.0×10−6/° K. The glass forms a strong bond to the platinum oxide on the surface of the platinum wire, and the matched thermal expansion coefficients minimize the thermal stress during cooling of the glass and platinum, thereby inhibiting cracking of the glass or separation of the glass from the electrode that could lead to drift in the oxygen sensor as the exposed platinum electrode area changes. Theglass bead 57 forms a reliable seal to theplatinum wire electrode 54, ensuring a stable platinum electrode area for drift-free operation of the device. The bond between the sealing glass and the oxidized platinum wire is much more tenacious and fluid-resistant than the bond formed by an adhesive used in prior oxygen sensor designs, rendering the present invention much more stable than a design based on an adhesive seal. Gluing theglass bead 57 into the end of thetube 52 and trimming the distal end of the platinum wire flush, or within one wire diameter of the tip of theglass bead 57 completes the oxygen electrode assembly. The twoelectrodes reference electrode 53 is coiled around thetube 52 and thesensing electrode 54 is exposed only at the tip of theglass bead 57, separated from thereference electrode 53 by a relatively large axial separation such as 1 mm. Additionally, theoxygen sensor 50 includes aconduit 59A, preferably formed from polyimide or other insulating tubing, for passage of theconductor 59 leading to the more distal pH-sensingelectrode 58. Theconductor 59 is electrically and physically isolated from the electrolyte solution in thesensor chamber 51 by multiple layers of insulation including the insulation on theelectrical conductor 59, the insulatingtubing conduit 59A, and the air or adhesive that fills the inner lumen of theconduit 59A. The electrolyte solution of theoxygen sensor 50 is contained in the annular space between thepolyimide tube 52 and thesleeve 20, and in the cylindrical space beyond the tip of theglass bead 57 and theplatinum sensing electrode 54. Thesleeve 20 preferably forms a large surface areacircumferential window 31 for theoxygen sensor 50, which is not easily blocked by close proximity to a blood vessel wall. -
FIG. 5 also shows a detailed view of the pH sensor contained within thesensor section 24 ofprobe 18. The pH sensor includes anoble metal electrode 58, such as a gold or platinum band, mounted on the external surface of theprobe 18 where it is directly exposed to the blood, and areference electrode reference electrode oxygen sensor 40 or thecarbon dioxide sensor 50. The pH-sensingelectrode 58 is attached to anelectrical conductor 59, such as an insulated copper wire, by soldering or welding. - As hereinbefore described, the probe is generally constructed from various wires, tubes, and electrodes, inserted into a bore of a
tubular sleeve 20, which is subsequently filled with adhesive and electrolyte solutions to form the sensors. In an alternative embodiment, a flexible circuit replaces the wires, tubes, and electrodes. The flexible circuit can be mass-produced in a batch process at low cost, thereby minimizing the cost of the multi-sensor probe.FIG. 6A shows aflexible circuit 60 which incorporates all of the electrical elements of a multi-sensor blood gas sensor probe, includingelectrical contact pads 62 comprising a low profileelectrical connector 22,electrical conductors 61, andsensing electrodes 63 through 68 of various types, all fabricated on a flexible planar substrate having three layers of circuitry separated by two layers of flexible insulating substrate such as polyimide. Such a flexible circuit can be manufactured using a known batch process wherein successive layers of conducting materials on insulating substrates are deposited by electroplating, vapor deposition, or other methods, then patterned by photolithography, laser ablation, or other methods. The patterned layers are bonded together with an insulating adhesive to complete the multi-layer flexible circuit. Once the processing steps have been completed, individual circuits are cut into narrow strips having a width such as 0.015 inch, such that the circuit can be inserted into asleeve 20 and filled with adhesive 33 and electrolyte solutions to form thesensor chambers flexible circuit 60. - The
flexible circuit 60 has a length, such as 25 cm, appropriate for the circuit to be situated longitudinally within the lumen of a sleeve and can have a width ranging from 0.008 inch to 0.030 inch and preferably 0.015 inch. The proximal end or portion of theflexible circuit 60 preferably has at least twopads 62, and more preferably sevenpads 62, which serve as theelectrical contacts 32 for a low profileelectrical connector 22. Theconnector pads 62 are plated with gold to provide reliable electrical contact with themating connector 15 of thedisplay module 12. The contact pads are connected to traces orconductors 61, sandwiched or disposed between first and second insulatinglayers inner surfaces respective layers traces 61 are in turn connected to a plurality of pads 63-66 and 68 near the distal end or portion of theflexible circuit 60, which serve as electrodes for the various sensors. The pads and traces of theflexible circuit 60 are primarily formed of copper, and the pads are plated with various metals including silver, platinum, and gold to create the electrodes of the various sensors. Thepads 62, 63-66 and 68 on one or both of the exposedouter surfaces traces 61 byfeedthrough vias 69 or any other suitable means. Thereference electrodes sensing electrode 64 for the carbon dioxide sensor is preferably formed by subjecting a platinum-plated pad to a known electrochemical process wherein the platinum metal is reacted in a platinum chloride solution to form a platinum dioxide layer on the surface of the platinum. Thesensing electrode 66 for the oxygen sensor is preferably formed by masking a platinum-plated pad electrode with an insulating material to define a small exposed area of platinum metal in the range from 0.001 inch to 0.008 inch in diameter, but preferably 0.002 inch in diameter. The pH-sensingelectrode 68 is preferably a gold-plated or platinum-plated pad, directly exposed to the blood. Theflexible circuit 60 can further accommodate a temperature sensor in the form of a patterned thin film of known material, forming a temperature-sensitive resistor 67 oninner surface 163 offirst layer 161. Alternatively, the temperature sensor can be a diode, thermistor, or thermocouple, bonded to one of the flexible circuit substrate layers 161 and 162. -
FIG. 6B shows theflexible circuit 60, including various electrodes, inserted into the lumen or bore of thesleeve 20, which is preferably sealed with adhesive 33 and filled with electrolyte solutions to form theinternal chambers flexible circuit 60 includes buried traces, which serve aselectrical conductors 61, and gold-plated pads, which serve aselectrical contacts 62 for theelectrical connector 22. The buried traces conduct electrical signals from thesensor electrodes 63 through 68 to theelectrical contacts pads 62, which serve as a low profileelectrical connector 22 that can be coupled to themating connector 15 of thedisplay module 12. - As hereinbefore described, at least the portion of the
polymer sleeve 20 that forms the external surface of theprobe 18 is preferably provided with adurable surface treatment 38 to inhibit the accumulation of thrombus, protein, or other blood components, which might otherwise impair blood flow in the artery or impede the transport of oxygen or carbon dioxide through thecircumferential window 31 into thesensing chamber 41 or 51 (seeFIG. 3 ). One preferred method for treating the surface of thesleeve 20 is photoinduced graft polymerization with N-vinylpyrrolidone to form a dense multitude of microscopic polymerized strands of polyvinylpyrrolidone, covalently bonded to the probe outer surface. Thissurface treatment 38 is durable, due to the strong covalent bonds, which anchor the polymer strands to the underlying substrate. Thesurface treatment 38 adds only a sub-micron thickness to theprobe body 20, yet it provides a hydrophilic character to the probe surface, rendering it highly lubricious when hydrated by contact with blood or water, thereby facilitating the smooth passage of theprobe 18 through the blood vessel. Thishydrophilic surface treatment 38 also inhibits the adsorption of protein onto the surface of the underlying polymer substrate, thereby minimizing the accumulation of thrombus, protein, or other blood components on theprobe 18. Although the dense multitude of polyvinylpyrrolidone polymer strands shields the underlying outer wall of the sleeve orcannula 20 from large protein molecules, it does not significantly impede the migration of small molecules such as oxygen or carbon dioxide through the wall of the cannula. Therefore, thesurface treatment 38 of thepolymethylpentene sleeve 20 facilitates consistent, reliable communication of the gases in the blood, such as oxygen and carbon dioxide, through thecircumferential window 31 into the oxygen and carbondioxide sensor chambers - One procedure for surface treatment of the polymer sleeve material is described hereinafter and is shown as a flowchart in
FIG. 7 . In preparation for the surface treatment process, two solutions are prepared, the sensitizingdilution 76 and thecoating solution 79. The sensitizingdilution 76 is prepared in two phases. In a first phase or step 74, performed under room light illumination, a blanket of nitrogen gas is applied to a volume of acetone, preferably 90 ml of acetone, after the acetone has been purged with nitrogen gas for a duration such as five minutes. In a second phase or step 75, performed under red light illumination, a mass of benzophenone, preferably 1.0 g of benzophenone, is dissolved in the acetone, with additional acetone added to the solution to make up a total volume of 100 ml. Thecoating solution 79 is prepared in two phases, both of which are carried out under room light illumination. In the first phase or step 77, a blanket of nitrogen gas is applied to a volume of distilled water in a flask, preferably 80 ml of distilled water, after the distilled water has been purged with nitrogen gas for a duration such as five minutes. In the second phase or step 78, while the nitrogen gas is still being applied, a mass of N-vinylpyrrolidone, preferably 11.4 grams of N-vinylpyrrolidone, is dissolved in the distilled water. The flask is capped and thecoating solution 79 is ready for storage or application. - A membrane tubing assembly is prepared for surface treatment in
step 70 by placing a mandrel inside a polymethylpentene tube of the proper length and sealing one end of the tube. In a preliminary phase or step 71 of the surface treatment procedure, performed under room light illumination, the membrane tubing assembly is immersed in methanol and sonicated for five minutes to thoroughly clean the outer surface, then allowed to air dry for five minutes. In a second phase or step 72 of the surface treatment procedure, performed under red light illumination, the membrane tubing assembly is dipped into a sensitizingdilution 76 of benzophenone in acetone for 30 seconds, under a nitrogen purge. The sensitized membrane tubing assembly is then removed and placed in a dessicator, still under red light illumination, dried for a duration such as five minutes under partial vacuum such as 28 mmHg, and stored in an amber vial with a nitrogen blanket. In a third phase or step 73 of the surface treatment procedure, performed under room light illumination, the sensitized membrane tubing assembly is dipped in a volume of the N-vinylpyrrolidone coating solution 79, such as 30 ml of solution, that has been heated to 60° C. The coating is cured by exposure to ultraviolet curing lights for a period such as 90 seconds, during which time the N-vinylpyrrolidone is polymerized to form a multitude of polyvinylpyrrolidone strands, covalently bonded to the membrane tubing substrate. The membrane tubing assembly is rinsed with copious amounts of distilled water, then placed in a dessicator to be dried under vacuum such as 28 mmHg for a period such as two hours to complete the preparation of the surface treated membrane tubing. - The surface treated polymethylpentene tubing may be used as the
sleeve 20 in the manufacture of a complete probe assembly, which will then retain the beneficial properties of the N-vinylpyrrolidone surface treatment. Alternatively, theprobe assembly 18 can be manufactured using untreated tubing, and the surface treatment can be subsequently applied to the completedprobe 18 using substantially the same method as describe hereinbefore. - The
display module 12, as shown in Figure I, includes ahousing 17 formed of a suitable material such as plastic and which is sized so that it can be worn on the patient, such as on the patient's wrist, arm or other limb, sometimes referred to herein as the subject, with the probe(s) 18 inserted into vessel(s) in the hand, wrist, or forearm. Themodule 12 also includes adisplay 13 such as a liquid crystal display (LCD) for displaying measured parameters and other information, and adapted to be readily visible to the attending medical professional, sometimes referred to herein as the user. Thedisplay 13 may include backlighting or other features that enhance the visibility of the display. Theband 14 attached to thehousing 17 is adapted to secure thedisplay module 12 to the subject's wrist. Alternatively, themodule 12 may be attached to the subject's arm or to a location near the subject. Optionally, in the case the subject is a newborn infant (neonate), themodule 12 may be strapped to the subject's torso, with the probe(s) 18 inserted into umbilical vessel(s). Theband 14 is comprised of any suitable material, such as Velcro, elastic, or the like.Buttons 16 or keys facilitate entry of data and permit the user to affect thedisplay 13 and other features of themodule 12. WhileFIG. 1 shows three buttons, any number or type of buttons, keypads, switches or the like may be used to permit entry of parameters or commands, or to otherwise interface with theapparatus 10. Themodule 12 may also include wireless communications capability to facilitate display of physiologic parameters on a remote monitor or computer system, and/or to facilitate the entry of patient parameters or other information into themodule 12 from a remote control panel or computer system. Themodule 12 also includes one ormore connectors 15 that provide physical connection and communication with one or more probes 18. Preferably, eachconnector 15 includes a receptacle adapted to receive, secure, and communicate with a correspondingconnector 22 on the proximal end of theprobe 18. - In a preferred embodiment of the
display module 12, the module is designed to be low in cost so that it can be packaged together with a probe(s) 18 and accessories as adisposable kit 100, with all of the components of the kit packaged together in a sterile pouch orother container 101, as illustrated inFIG. 10 . In addition to thedisplay module 12 and probe(s) 18, the kit would optionally include aprobe holder 102 to protect the probe from damage or degradation, awrist band 14 or other means for attaching the display module to a patient, a needle orother introducer 103,alcohol swabs 104 for cleaning the skin prior to cannulating the vessel and for cleaning blood or other residue from the probe connector prior to attaching the probe to the module, abandage 105 to cover the puncture site and anchor the probe in place, and any other items that may be utilized for preparing and using theprobe 18 anddisplay module 12. Thedisplay module 12 is further designed to require low power so that it can operate for the expected lifetime of the device, such as 72 hours, on battery power without the need for battery replacement or connection to an external power source. Theprobe 18 is preferably suited to be a single-use, disposable device, since it has a limited operational lifetime and is used in direct contact with the subject's blood. Themodule 12 is durable enough to be used many times, however, the advantage of a disposable module is that it eliminates the expense and the infection hazard associated with cleaning, replacing batteries, and reusing a single module for multiple patients. An additional advantage of adisposable module 12 packaged together with its associated probe(s) 18 is that the calibration data can be stored in the module at the time of manufacture, greatly simplifying the use of theapparatus 10 by eliminating the need for the user to enter calibration data into the module prior to using theprobe 18. An additional advantage of adisposable module 12 packaged together with its associated probe(s) 18 is that the calibration data stored in the module at the time of manufacture can account for all of the monitor and probe inaccuracies and artifacts in a single set of calibration coefficients, thereby avoiding the accumulation of inaccuracies that can occur with separate calibrations of theprobe 18 and themodule 12. In a preferred embodiment of the module, no user inputs at all are required, eliminating the need for buttons, keypads, switches, and the like. Thedisplay module 12 is automatically energized upon connection of theprobe 18 to themodule 12, and all of the calibration data and other needed information is pre-programmed into the module at the time of manufacture. - One embodiment of the
electronic circuitry 80 included in thedisplay module 12 is shown in block diagram form inFIG. 8 . As shown therein, signals from the one or more sensors provided on the one or more probe(s) 18 arrive at thedisplay module 12 via connector(s) 15. The sensor signals are received by a respective plurality of analogsignal conditioning circuits 82, one for each sensor in the associated probe(s) 18. The outputs from the analogsignal conditioning circuits 82 are directed to amicrocontroller 81, such as the Texas Instruments MSP430F435, which includes many of the circuit elements required by thedisplay module 12. In particular, themicrocontroller 81 includes an analog multiplexer and an analog-to-digital converter to digitize the analog signals from the plurality of analogsignal conditioning circuits 82, as well as analog support circuitry including a voltage reference, a temperature sensor, and power supply monitoring circuitry. In one preferred embodiment, the algorithm for processing the signals, together with the sensor and module calibration coefficients, is embedded in software stored in non-volatile memory included in themicrocontroller 81. Themicrocontroller 81 further includes a central processing unit to execute the software algorithm and other peripheral functions including clock circuitry, serial and parallel input/output interfaces, timers, and the LCD driver circuitry. The LCD driver circuitry supplies the waveforms for theliquid crystal display 13, and thedisplay module 12 can also communicate with an external computer or module over a serial data link via an optionalwireless interface circuit 83 or other suitable means. The integration of most of the required functions of the display module circuitry into a single, inexpensive, low-power component, that is the microcontroller, makes it feasible to manufacture the module as a low cost, battery-powered disposable unit. - Each of the analog
signal conditioning circuits 82 is adapted to the particular type of sensor to which it is connected. For the oxygen sensor, the analog signal conditioning circuit can be a current-to-voltage converter with a full-scale input current that includes the maximum full-scale current expected for the oxygen sensor, such as 100 nanoamps, and a full-scale output voltage matched to the analog-to-digital converter input range. The input bias current for the oxygen sensor circuit is preferably much less than the normal sensor operating current, such as an input bias current of less than 100 picoamps. For the carbon dioxide or pH sensor, the analog signal conditioning circuit can be a voltage amplifier with very high input impedance, such as greater than 1012 ohms, and very low input bias and input offset currents, such as less than 100 femtoamps. The circuit can include a fixed gain and offset voltage chosen to translate the full-scale sensor voltage range to match the analog-todigital converter input range. The carbon dioxide or pH sensor circuit requirements may be satisfied by an instrumentation amplifier or by a simpler operational amplifier circuit, with the amplifier selected to provide the required low input bias and offset currents. For the thermocouple temperature sensor, the analog signal conditioning circuit can be a high gain voltage amplifier with an input voltage range of zero to 2 millivolts over the expected temperature range, and an output voltage to match the analog-to-digital converter input range. For the required high gain thermocouple signal conditioning circuit, the amplifier is preferably chosen to provide an input offset voltage much less than the signal voltage, such as an input offset voltage of less than 10 microvolts. - One
processing algorithm 90 that can be performed by themicrocontroller 81 to convert the digitized sensor signals into displayable numeric values is shown in block diagram form inFIG. 9 . The processing algorithm includes the steps of digitizing the sampled sensor outputs instep 91, temporal filtering or averaging to reduce the noise from external interference or other sources instep 92, correcting for gain or offset errors in the analog signal conditioning circuitry instep 93, incorporating gain, offset, and linearity corrections from the sensor calibration data instep 94, compensating for the temperature dependence of the gain, offset and linearity of the sensor according to the measured probe temperature instep 95, and translating the value into the desired units for display on the LCD instep 96. In practice, if themodule 12 andprobe 18 are calibrated together as a single disposable apparatus, then all of the gain, offset, nonlinearity, temperature, and unit conversion factors fromsteps step 97 of calculating other physiologic parameters according to known formulas, possibly combining readings from multiple sensors, or combining multiple readings from a single sensor to provide additional useful information. - An example of a calculation based on a single reading from a single sensor is the estimation of arterial or venous oxygen saturation (SaO2 or SvO2) from the corresponding measured partial pressure of oxygen (PaO2 or PvO2). There is a known nonlinear relationship between the oxygen saturation and the partial pressure of oxygen in blood, but the saturation value is useful for calculating cardiac output and for other assessments of patient status.
- An example of a calculation based on multiple readings from a single sensor is the determination of the trend in the associated blood gas parameter, that is, whether the value is increasing, decreasing, or stable. The trend in the blood gas parameter can be symbolically indicated on the display, making it easier for the user to quickly assess patient status.
- An example of a calculation based on combined readings from multiple sensors is the use of the carbon dioxide reading and the pH measurement to calculate the bicarbonate level. According to a known relationship, the log of the bicarbonate concentration is equal to the pH, plus the log of the partial pressure of CO2, minus the constant 7.608. This equation is appropriate for blood at 37° C., and it may be further compensated for temperature deviation from normal.
- An example of a calculation based on combined readings from multiple sensors on multiple probes is the use of an arterial oxygen reading and a venous oxygen reading to estimate the cardiac output using a modified version of the Fick oxygen consumption method. According to the Fick method, cardiac output (liters/minute) is calculated as the oxygen consumption (milliliters/minute), divided by the arteriovenous oxygen concentration difference (milliliters of O2 per liter of blood). For the present invention, oxygen consumption is estimated as 3 milliliters/kilogram times the subject's weight, which can be entered into the module by way of the buttons or keys, or by way of a wireless communication from an external computer or control panel. Assuming standard values for hemoglobin (12.5 grams/deciliter) and the oxygen carrying capacity of hemoglobin (1.36 milliliters of O2 per gram of hemoglobin), the arteriovenous oxygen concentration difference can be calculated as the difference between the arterial oxygen saturation and the venous oxygen saturation (SaO2−SvO2) times the standard value of 170 milliliters of O2 per liter of blood. In this calculation, the value of the venous oxygen saturation may be adjusted to compensate for the experimentally determined discrepancy between the pulmonary artery oxygen saturation and the forearm venous oxygen saturation.
- The incorporation of wireless interface circuitry into the display module is advantageous in preserving the electrical safety and freedom of movement of the patient afforded by the self-contained, battery-powered display unit, while providing the benefits of an integrated system in terms of centralized data collection. The compact display module of the present invention makes the most of the wireless communications by freeing the subject from the tubes and cables that normally tether them to their bed, and by eliminating the need for additional bulky instrumentation at the already crowded bedside.
- From the foregoing it can be seen that the
apparatus 10 and method of the present invention makes it possible to measure blood gases of a subject, such as oxygen and carbon dioxide, as well as other blood parameters including temperature and pH. As hereinbefore described, a single probe may include more than one sensor, e.g., an oxygen sensor, a carbon dioxide sensor, a temperature sensor, and a pH sensor. The sensors are included in a probe body, having a small diameter of less than 0.023″ so that it can be readily inserted through a 20-gauge needle into a blood vessel in the hand, wrist, or forearm. This probe includes at least one sensor with awindow 31 having a large surface area and high permeability to the target gas molecules, which facilitates the rapid diffusion of blood gases into or out of the sensor chamber to ensure a fast response to changes in the blood gas concentration. The probes utilized are preferably blunt tipped and atraumatic to the vessel wall and are preferably provided with an antithrombogenic surface treatment to inhibit the formation of thrombus or the adhesion of protein or other blood components, ensuring consistent performance of the blood gas sensors and minimizing the need for continuous infusion of heparin to maintain a clot-free environment. The probe carries electrical signals from the sensors, through electrical conductors, to a low profile or other connector removably attached to a mating connector on the display module. The low profile of the preferred connector facilitates the removal of the hypodermic needle or other introducer used to most simply introduce the probe into the lumen of a vein or artery, thereby eliminating the need for using a split sheath introducer or other more complex technique for introducing the probe into the vessel. The display module is small and inexpensive, and it is particularly suited for attachment to the patient's wrist. The apparatus and method herein described may be adapted to the particular requirements of a variety of different medical applications, several of which are outlined below. - For patients in the intensive care unit (ICU) or coronary care unit (CCU), there is typically the need for monitoring arterial blood gases (oxygen and carbon dioxide) and pH. Currently, this monitoring is performed on an intermittent basis, typically three to twelve times per day, by drawing a blood sample from an arterial line in the patient's forearm, and delivering the blood sample to a blood gas analyzer. A multi-sensor probe as described herein, providing continuous oxygen, carbon dioxide, and pH measurements, can eliminate the need and the associated expense and risks of placing and maintaining an arterial line and repeatedly drawing blood samples therefrom. Furthermore, the continuous monitoring provided by the present invention gives rapid feedback regarding the effects of any interventions such as adjustments to the ventilator settings or administration of drugs. The timely feedback on the effects of the medical interventions permits the subject to be more quickly weaned from the ventilator and released from the ICU/CCU, a benefit to the both the patient and the healthcare system.
- In a subset of ICU/CCU patients, where there is a need to monitor cardiac output, the addition of a venous oxygen sensor probe to the previously described multi-sensor arterial probe, makes it possible for the present invention to estimate the cardiac output using a modified arteriovenous oxygen concentration difference equation (the Fick method) as hereinbefore described. Currently, cardiac output is most frequently monitored using the thermodilution technique, which requires placement of a Swan-Ganz catheter in the jugular vein, through the right atrium and right ventricle, and into a branch of the pulmonary artery. The thermodilution technique requires injections of cold saline boluses at intervals, whenever a cardiac output reading is desired. The replacement of the right heart catheter with the present invention greatly reduces the risk to the patient by eliminating the right heart catheterization procedure, and it provides greater utility by providing on demand cardiac output readings without cumbersome injections of cold saline.
- In another subset of ICU/CCU patients, where there is a need to frequently monitor cardiac output but not arterial blood gases, a simpler apparatus is a single venous oxygen probe used to monitor the venous oxygen content. This value is combined with independent measurements of arterial oxygen saturation from a noninvasive pulse oximeter, hemoglobin density from a daily blood sample, and calculated oxygen consumption according to the standard approximation based on weight and height, to calculate cardiac output according to the Fick method. The probe is placed in a vein in the hand, using an experimentally determined compensation factor to account for the expected difference between the oxygen saturation in the right atrium and the oxygen saturation in a vein of the hand. Alternatively, the oxygen probe can be inserted directly through the jugular vein in the neck, into the vena cava or the right atrium of the heart to provide a direct measurement of the oxygen saturation of the mixed venous blood without the need for a compensation factor. Besides its utility for estimating cardiac output, the venous oxygen content is a valuable parameter on its own for assessing the status of the patient.
- In neonates, there is frequently the need for arterial and venous blood gas monitoring, along with the measurement of cardiac output and other blood parameters. The present invention is particularly suitable for neonates, since it minimizes if not eliminates the need for drawing blood from the neonate subject with a small blood volume to draw from. The addition of hemoglobin, bilirubin, electrolyte, or glucose sensors to the blood gas and pH sensors increases the utility of the multi-sensor probe for this application. The probes are conveniently inserted into umbilical arteries and veins, and the display module is appropriate in size to be strapped around the abdomen of a neonate.
- In diagnosing congenital heart defects in neonate and pediatric patients, there is often a need to sample the oxygen saturation in a variety of locations throughout the chambers of the heart and in the great vessels. This oxygen saturation data is normally collected in conjunction with an angiographic study of the heart, and it permits the operation of a malformed heart to be more accurately diagnosed, thereby resulting in more appropriate treatment for the patient. Currently, oxygen saturation data is collected by drawing multiple blood samples through a small catheter from a variety of locations throughout the heart and the great vessels. These blood samples are sequentially transferred to a blood gas analyzer to obtain an oxygen saturation reading for each sample. Using the technology of the present invention, a small oxygen sensor mounted on a probe or guidewire of suitable size such as less than 0.023″ in diameter and 50 to 150 cm in length can be advanced through a guiding catheter to various locations in the heart and the great vessels to sample the oxygen saturation in vivo, thereby reducing the risk to the patient by eliminating the need to draw a large number of blood samples from a small subject and by reducing the time for the procedure.
- In one aspect of the invention, an apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood is provided. The apparatus comprises a display module and a probe having a distal extremity adapted to be inserted into the vessel of the patient and having a proximal extremity coupled to the display module. The probe includes a gas sensor assembly mounted in the distal extremity for providing an electrical signal to the display module when the probe is disposed in the blood. The probe has an antithrombogenic surface treatment for inhibiting the adhesion of blood components to the probe when disposed in the blood.
- In another aspect of the invention, a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood is provided. The probe comprises a cannula adapted to be inserted into the vessel of the patient and a gas sensor assembly mounted inside the cannula. The cannula has an antithrombogenic surface treatment for inhibiting the adhesion of blood components to the cannula when disposed in the blood.
- In a further aspect of the invention, a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood is provided. The probe comprises a cannula having proximal and distal extremities, the distal extremity being adapted to be inserted into the vessel of the patient. A gas sensor assembly is mounted inside the distal extremity of the cannula. The cannula has an annular window of a gas permeable material extending around the gas sensor assembly.
- Another aspect of the invention provides a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood. The probe comprises a cannula having proximal and distal extremities, the distal extremity being adapted to be inserted into the vessel of the patient. An electrolyte solution is disposed in the cannula. A gas sensor assembly is mounted in the distal extremity of the cannula and includes an electrode disposed in the electrolyte solution. A conductor extends to the electrode and a sealing glass extends around the conductor. The conductor has a coefficient of thermal expansion and the sealing glass has a coefficient of thermal expansion approximating the coefficient of thermal expansion of the conductor for inhibiting separation of the conductor from the sealing glass and thus inhibiting the electrolyte solution from creeping between the conductor and the sealing glass.
- A further aspect of the invention provides an apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood. The apparatus comprises a display module and a probe, the probe having proximal and distal extremities. The distal extremity of the probe is adapted to be inserted into the vessel of the patient and has a gas sensor assembly for providing an electrical signal when the probe is disposed in the blood. The display module has a first connector and the proximal extremity of the probe has a second connector for mating with the first connector. The second connector has a cylindrical portion and an electrical contact extending around at least a portion of the cylindrical portion. A conductor extends though the probe for electrically coupling the gas sensor assembly with the electrical contact. The electrical contact is seated flush with the cylindrical portion so as to provide the second connector with a substantially smooth cylindrical surface. The first and second connectors permit connection and disconnection between the probe and the display module.
- In yet another aspect of the invention, a probe for use with an introducer in a patient having a vessel carrying blood to ascertain characteristics of the blood is provided. The probe comprises a cannula having proximal and distal extremities. The distal extremity of the cannula is adapted to be inserted into the vessel of the patient. A gas sensor assembly is disposed in the distal extremity of the cannula for providing an electrical signal when the cannula is disposed in the blood. A connector is provided on the proximal extremity of the cannula. The distal extremity of the cannula is adapted for slidable travel through the introducer when inserting the cannula into the vessel. The cannula and connector have a size which permits the introducer to be slid off of the proximal extremity of the cannula and the connector after the distal extremity of the cannula has been inserted into the vessel.
- An aspect of the invention also provides an apparatus for use with a patient having a vessel carrying blood to ascertain characteristics of the blood. The apparatus comprises a compact display module and a probe, the probe having a proximal extremity coupled to the display module and a distal extremity adapted to be inserted into the vessel of the patient. The distal extremity includes a sensor for providing an electrical signal to the display module when the probe is disposed in the blood. The probe has calibration coefficients. The display module has a processor for processing the electrical signal to provide a reading and a memory for storing the calibration coefficients. The processor is coupled to the memory to permit access by the processor to the calibration coefficients in connection with the processing of the electrical signal so as to enhance the accuracy of the reading.
- A kit for use with a patient having a vessel carrying blood to ascertain characteristics of the blood is provided in another aspect of the invention. The kit comprises a package. A probe is carried within the package. The probe has a distal extremity adapted to be inserted into the vessel of the patient and includes a sensor for providing an electrical signal. The probe has calibration coefficients. A compact display module is carried within the package and has a processor and a nonvolatile memory coupled to the processor. The calibration coefficients are stored in the memory of the display module. When the probe is coupled to the display module and the distal extremity inserted into the vessel and an electrical signal is received by the display module for providing a reading, the processor accesses the memory so as to utilize the calibration coefficients and thus enhance the accuracy of the reading.
- A further aspect of the invention provides a probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood. The probe comprises a cannula adapted to be inserted into the vessel of the patient and having proximal and distal extremities. An electrolyte solution is disposed in the distal extremity of the cannula. A gas sensor assembly is mounted in the distal extremity of the cannula and is disposed in the electrolyte solution. The gas sensor assembly has a tube with a distal portion and a first electrode coiled around the tube. A second electrode is carried by the distal portion of the tube. First and second conductors extend from the proximal extremity of the cannula to the gas sensor assembly, the first conductor being coupled to the first electrode and the second conductor extending through the tube and being coupled to the second electrode. The tube serves as support for the first electrode and as a conduit for the second conductor.
- A probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood is also provided. The probe comprises a cannula having proximal and distal extremities. The distal extremity is adapted to be inserted into the vessel of the patient. A flex circuit extends through at least a portion of the cannula. The flex circuit has proximal and distal portions with first and second electrodes formed on the distal portion and first and second conductors extending from the proximal portion to the first and second electrodes. An electrolyte solution is disposed in the distal extremity of the cannula in the vicinity of the first and second electrodes.
- Numerous probes and display modules according to the present invention have been fabricated and tested to demonstrate the feasibility and performance of the device. The following experimental data illustrates the typical performance of the invention under experimental conditions.
-
Chart 1 shows the performance of a representative example of an oxygen sensor probe over a range of dissolved oxygen concentrations from zero to 150 mmHg partial pressure of oxygen. The response is linear over the range of interest, making the calibration to 5% accuracy a simple process. - Besides exhibiting accuracy and linearity, the oxygen sensor provides rapid response to changes in the dissolved oxygen concentration.
Chart 2 shows the time response of a representative oxygen sensor probe to a sequence of step changes in oxygen partial pressure, demonstrating a settling time of less than 3 minutes to a within 5% of the final value.
Besides demonstrating accuracy, linearity, and rapid response, the oxygen sensor provides greater than 72 hours of longevity to satisfy the requirements of the ICU/CCU monitoring application. Chart 3 shows the stability of the oxygen sensor output over the course of a 90-hour longevity study. With a constant, room air, partial pressure of oxygen of 150 mmHg, the output of the sensor remains nearly constant for greater than 72 hours except for the expected small variations in output due to temperature fluctuations and noise. - Chart 4 shows the performance of a representative example of a carbon dioxide sensor probe over a range of dissolved carbon dioxide concentrations from 10 to 100 mmHg partial pressure of carbon dioxide. The response shows the classic logarithmic performance expected for this type of pH-responsive sensor, making calibration to 5% accuracy a simple process.
- Besides exhibiting accuracy and linearity, the carbon dioxide sensor provides rapid response to changes in the dissolved carbon dioxide concentration.
Chart 5 shows the time response of a representative carbon dioxide sensor probe to a sequence of step changes in carbon dioxide partial pressure, demonstrating a settling time of less than three minutes to a within 5% of the final value.
Besides demonstrating accuracy, linearity, and rapid response, the carbon dioxide sensor has an inherently long lifetime, since it does not consume the electrodes or the electrolyte solution as the oxygen sensor does. - Chart 6 shows the performance of a representative pH sensor output over a range of pH from 4 to 10. This pH sensor is mounted in a multi-sensor probe that also includes oxygen, carbon dioxide, and temperature sensors. The response shows the classic linear voltage response to the logarithmic pH parameter. The standard deviation for repeated measurements at a single pH value is approximately 0.02 pH, demonstrating that calibration to the required 0.05 pH accuracy over the physiological range of pH from 7 to 8 is feasible.
- The response time of the pH sensor is fast, with a settling time of approximately 10 seconds to a step change in the pH value.
- This sample data shows that the oxygen, carbon dioxide, and pH sensors according to the present invention provide the accuracy, response time, and longevity to meet the needs of the medical monitoring applications for which it is intended. All of the sample probes have outside diameters of 0.020″ as described in the preferred embodiment, and a single probe includes the four oxygen, carbon dioxide, temperature, and pH sensors. While the invention is susceptible to various modifications and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but rather the invention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the appended claims.
Claims (21)
1. A probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood comprising a cannula having proximal and distal extremities, the distal extremity being adapted to be inserted into the vessel of the patient, an electrolyte solution disposed in the cannula, a gas sensor assembly mounted in the distal extremity of the cannula and including an electrode disposed in the electrolyte solution, a conductor extending to the electrode and a sealing glass extending around the conductor, the conductor having a coefficient of thermal expansion and the sealing glass having a coefficient of thermal expansion approximating the coefficient of thermal expansion of the conductor for inhibiting separation of the conductor from the sealing glass and thus inhibiting the electrolyte solution from creeping between the conductor and the sealing glass.
2. The probe of claim 1 wherein the conductor has a cleaved extremity to form an active area of the electrode.
3. The probe of claim 2 wherein the conductor is made of platinum.
4. The probe of claim 1 wherein the gas sensor assembly includes an additional electrode disposed in the electrolyte solution.
5. A probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood comprising a cannula adapted to be inserted into the vessel of the patient and having proximal and distal extremities, an electrolyte solution disposed in the distal extremity of the cannula, a gas sensor assembly mounted in the distal extremity of the cannula and disposed in the electrolyte solution, the gas sensor assembly having a tube with a distal portion and a first electrode coiled around the tube and a second electrode carried by the distal portion of the tube, first and second conductors extending from the proximal extremity of the cannula to the gas sensor assembly, the first conductor being coupled to the first electrode and the second conductor extending through the tube and being coupled to the second electrode whereby the tube serves as support for the first electrode and as a conduit for the second conductor.
6. The probe of claim 5 wherein the gas sensor assembly includes a sealing glass extending around the second conductor at the distal portion of the tube for forming the second electrode.
7. The probe of claim 6 wherein the second conductor has a coefficient of thermal expansion and the sealing glass has a coefficient of thermal expansion approximating the coefficient of thermal expansion of the second conductor for inhibiting separation of the conductor from the sealing glass and thus undesirably permitting the electrolyte solution to creep between the conductor and the sealing glass.
8. The probe of claim 5 wherein the second conductor has a distal end portion made of platinum.
9. The probe of claim 5 wherein the first electrode is a reference electrode and the second electrode is a carbon dioxide electrode.
10. The probe of claim 5 wherein first electrode is a reference electrode and the second electrode is an oxygen electrode.
11. A probe for use in a patient having a vessel carrying blood to ascertain characteristics of the blood comprising a cannula having proximal and distal extremities, the distal extremity being adapted to be inserted into the vessel of the patient, a flex circuit extending through at least a portion of the cannula, the flex circuit having proximal and distal portions with first and second electrodes formed on the distal portion and first and second conductors extending from the proximal portion to the first and second electrodes, an electrolyte solution disposed in the distal extremity of the cannula in the vicinity of the first and second electrodes.
12. The probe of claim 11 wherein the cannula is gas permeable in the vicinity of the first and second electrodes.
13. The probe of claim 12 wherein the entire cannula is made of a gas permeable material.
14. The probe of claim 13 wherein the gas permeable material is polymethylpentene.
15. The probe of claim 11 wherein the flex circuit includes first and second layers of an insulating material, the first and second conductors extending along and between the first and second layers.
16. The probe of claim 15 wherein each of the first and second layers has an exposed surface, the first and second electrodes each being a pad formed on one of the exposed surfaces of the first and second layers.
17. The probe of claim 11 wherein the flex circuit includes at least one layer of insulating material, first and second contact pads formed on the at least one layer of insulating material at the proximal portion of the flex circuit and coupled respectively to the first and second conductors, the first and second contact pads permitting electrical communication with the flex circuit outside of the patient.
18. The probe of claim 17 wherein the distal extremity of the cannula is adapted for slidable travel through an introducer when inserting the cannula into the vessel, the cannula and the flex circuit having a size which permits the introducer to be slid off of the proximal extremity of the cannula and the flex circuit after the distal extremity of the cannula has been inserted into the vessel.
19. The probe of claim 11 further comprising adhesive disposed within the cannula for securing the flex circuit within the cannula.
20. The probe of claim 19 wherein the cannula is provided with a sealed chamber in which the first and second electrodes are located, the electrolyte solution being disposed in the sealed chamber.
21. The probe of claim 20 wherein the cannula is provided with an additional sealed chamber in which third and fourth electrodes are located, the electrolyte solution being disposed in the additional sealed chamber.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/027,902 US20080139909A1 (en) | 2003-09-09 | 2008-02-07 | Sensor with conductor and sealing glass |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/658,926 US7630747B2 (en) | 2003-09-09 | 2003-09-09 | Apparatus for ascertaining blood characteristics and probe for use therewith |
US12/027,902 US20080139909A1 (en) | 2003-09-09 | 2008-02-07 | Sensor with conductor and sealing glass |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/658,926 Division US7630747B2 (en) | 2003-09-09 | 2003-09-09 | Apparatus for ascertaining blood characteristics and probe for use therewith |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080139909A1 true US20080139909A1 (en) | 2008-06-12 |
Family
ID=34226879
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/658,926 Expired - Fee Related US7630747B2 (en) | 2003-09-09 | 2003-09-09 | Apparatus for ascertaining blood characteristics and probe for use therewith |
US12/027,933 Abandoned US20080125633A1 (en) | 2003-09-09 | 2008-02-07 | Probe and display having a gas sensor assembly and surface treatment |
US12/027,902 Abandoned US20080139909A1 (en) | 2003-09-09 | 2008-02-07 | Sensor with conductor and sealing glass |
US12/027,915 Abandoned US20080125635A1 (en) | 2003-09-09 | 2008-02-07 | Probe with gas permeable material surrounding a gas sensor assembly |
US12/027,898 Abandoned US20080146903A1 (en) | 2003-09-09 | 2008-02-07 | Display and probe having a removable connections |
US12/027,905 Abandoned US20080125632A1 (en) | 2003-09-09 | 2008-02-07 | Sensor probe and display module |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/658,926 Expired - Fee Related US7630747B2 (en) | 2003-09-09 | 2003-09-09 | Apparatus for ascertaining blood characteristics and probe for use therewith |
US12/027,933 Abandoned US20080125633A1 (en) | 2003-09-09 | 2008-02-07 | Probe and display having a gas sensor assembly and surface treatment |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/027,915 Abandoned US20080125635A1 (en) | 2003-09-09 | 2008-02-07 | Probe with gas permeable material surrounding a gas sensor assembly |
US12/027,898 Abandoned US20080146903A1 (en) | 2003-09-09 | 2008-02-07 | Display and probe having a removable connections |
US12/027,905 Abandoned US20080125632A1 (en) | 2003-09-09 | 2008-02-07 | Sensor probe and display module |
Country Status (8)
Country | Link |
---|---|
US (6) | US7630747B2 (en) |
EP (1) | EP1662977A4 (en) |
JP (1) | JP2007516005A (en) |
CN (1) | CN101052343B (en) |
CA (1) | CA2538122A1 (en) |
HK (1) | HK1113735A1 (en) |
MX (1) | MXPA06002733A (en) |
WO (1) | WO2005023097A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050054905A1 (en) * | 2003-09-09 | 2005-03-10 | Corl Paul D. | Apparatus for ascertaining blood characteristics and probe for use therewith |
US20090209849A1 (en) * | 2007-05-02 | 2009-08-20 | Philip Stephen Rowe | Medical Device Placement and Monitoring System Utilizing Radio Frequency Identification |
US20100010328A1 (en) * | 2008-07-11 | 2010-01-14 | Nguyen Harry D | Probes and sensors for ascertaining blood characteristics and methods and devices for use therewith |
US20100033188A1 (en) * | 2008-08-05 | 2010-02-11 | Rieth Harry T | Apparatus, method and system for determining a physiological condition within a mammal |
US20100057046A1 (en) * | 2008-09-03 | 2010-03-04 | Keimar, Inc | Systems for characterizing physiologic parameters and methods for use therewith |
US20100204556A1 (en) * | 2009-02-12 | 2010-08-12 | Keimar, Inc. | Physiological parameter sensors |
US20170167186A1 (en) * | 2015-12-15 | 2017-06-15 | Sage Electrochromics, Inc. | Insulated glazing units and electrical feed throughs |
US11504517B2 (en) | 2015-12-11 | 2022-11-22 | Nxstage Medical, Inc. | Fluid line connector devices methods and systems |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US7559894B2 (en) * | 2003-09-18 | 2009-07-14 | New Paradigm Concepts, LLC | Multiparameter whole blood monitor and method |
GB0324450D0 (en) * | 2003-10-20 | 2003-11-19 | Alertis Medical As | Sensor |
US8364230B2 (en) * | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US8425416B2 (en) * | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8774886B2 (en) * | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
US7494470B1 (en) * | 2004-09-10 | 2009-02-24 | Pacesetter Inc. | Analysis of metabolic gases by an implantable cardiac device for the assessment of cardiac output |
US8277386B2 (en) * | 2004-09-27 | 2012-10-02 | Volcano Corporation | Combination sensor guidewire and methods of use |
US8187195B2 (en) * | 2005-10-12 | 2012-05-29 | Radi Medical Systems Ab | Sensor wire assembly |
US7481402B2 (en) * | 2006-04-28 | 2009-01-27 | Candice Woodward | Electrostatic dissipative ergonomic forearm support |
DE102006032905A1 (en) * | 2006-04-28 | 2007-10-31 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Sensor e.g. optical sensor, calibrating and/or adjusting method, involves designing evaluation electronics so that signal produced by sensor is not changeable, where sensor is adjusted at place other than subsequent measuring point |
US8298142B2 (en) * | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8447376B2 (en) * | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
TW200835463A (en) * | 2006-12-27 | 2008-09-01 | Koninkl Philips Electronics Nv | Method and apparatus for measuring fluid properties, including pH |
US8845530B2 (en) | 2007-01-02 | 2014-09-30 | Isense Corporation | Resposable biosensor assembly and method of sensing |
WO2008090485A1 (en) * | 2007-01-25 | 2008-07-31 | Nxp B.V. | A sensor module for a catheter |
US20080249388A1 (en) * | 2007-04-06 | 2008-10-09 | Thinkvillage, Llc | Systems and methods for cooling of intravenous fluid and monitoring of in vivo characteristics |
US8412293B2 (en) * | 2007-07-16 | 2013-04-02 | Optiscan Biomedical Corporation | Systems and methods for determining physiological parameters using measured analyte values |
US7925347B1 (en) | 2007-11-26 | 2011-04-12 | Pacesetter, Inc. | Assessment of cardiac output by implantable medical device |
US20090156921A1 (en) * | 2007-12-18 | 2009-06-18 | Huisun Wang | Cardiac ablation catheter with oxygen saturation sensor |
US20090156916A1 (en) * | 2007-12-18 | 2009-06-18 | Huisun Wang | Catheter systems with blood measurement device and methods |
EP2259712A1 (en) * | 2008-03-03 | 2010-12-15 | Geisert Square Gmbh | Intervertebral disc analysis system and method |
US11375929B2 (en) * | 2008-10-15 | 2022-07-05 | The University Of Tennessee Research Foundation | Method and device for detection of bioavailable drug concentration in a fluid sample |
US20100280328A1 (en) * | 2009-05-01 | 2010-11-04 | Tyco Healthcare Group, Lp | Methods and systems for illumination during phlebectomy procedures |
SE0901166A1 (en) * | 2009-09-10 | 2011-03-11 | Cathprint Ab | Flexible catheter lead carrier provided with such lead carrier |
WO2011062683A1 (en) * | 2009-11-20 | 2011-05-26 | Keimar, Inc. | Systems for intravascular measurement |
DE202010011934U1 (en) * | 2010-08-27 | 2011-02-10 | Nawa-Heilmittel Gmbh | Medical hand-held device |
WO2012142502A2 (en) | 2011-04-15 | 2012-10-18 | Dexcom Inc. | Advanced analyte sensor calibration and error detection |
EP2910186B1 (en) | 2011-04-22 | 2019-02-27 | Topera, Inc. | Basket style cardiac mapping catheter having an atraumatic, metallic two-part distal tip for detection of cardiac rhythm disorders |
WO2013022911A1 (en) | 2011-08-10 | 2013-02-14 | Wristdocs Llc | Biotelemetry system |
AU2012321050A1 (en) * | 2011-10-04 | 2014-04-17 | Smartstent Pty Ltd | Sensing or stimulating activity of tissue |
US9734938B2 (en) * | 2011-10-06 | 2017-08-15 | 3Dt Holdings, Llc | Devices and systems for obtaining conductance data and methods of manufacturing and using the same |
US11373780B2 (en) | 2011-10-06 | 2022-06-28 | 3Dt Holdings, Llc | Methods to generate elongated wires having a metallic substrate thereon and devices comprising the same |
US20130109980A1 (en) * | 2011-11-01 | 2013-05-02 | Tat-Jin Teo | Systems and methods for a wireless vascular pressure measurement device |
JP5749806B2 (en) * | 2011-11-01 | 2015-07-15 | パナソニックヘルスケアホールディングス株式会社 | Biological sample measuring device |
SE536219C2 (en) * | 2011-12-05 | 2013-07-02 | St Jude Medical Systems Ab | Active noise canceling device for medical intracorporeal sensors |
GB201210439D0 (en) * | 2012-06-13 | 2012-07-25 | Softcell Medicals | Apparatus |
US20140187978A1 (en) * | 2012-12-28 | 2014-07-03 | Volcano Corporation | Intravascular Devices Having Information Stored Thereon And/Or Wireless Communication Functionality, Including Associated Devices, Systems, And Methods |
TW201444529A (en) | 2013-05-20 | 2014-12-01 | Wristdocs Llc | Pulse oximeter sensor |
CN104224160B (en) * | 2013-06-20 | 2018-12-04 | 珠海凯迪莱医疗科技有限公司 | Cardiac output detector radio transmitting device |
CN104739400B (en) * | 2013-12-31 | 2020-09-15 | 深圳迈瑞生物医疗电子股份有限公司 | Automatic cardiac output measuring system |
WO2015108666A2 (en) * | 2014-01-14 | 2015-07-23 | St. Jude Medical, Cardiology Division, Inc. | Sensor-bearing tip and medical device including the same |
SE539551C2 (en) * | 2014-06-19 | 2017-10-10 | Cathprint Ab | Conductor device with a resilient tubular outer casing with flexible pattern board in the outer casing |
JP6229077B2 (en) * | 2014-07-11 | 2017-11-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Ablation medical devices |
US12220259B2 (en) * | 2015-07-17 | 2025-02-11 | Philips Image Guided Therapy Corporation | Intravascular devices systems and methods with an adhesively attached shaping ribbon |
KR102239996B1 (en) | 2015-10-20 | 2021-04-15 | 더 유니버시티 오브 멜버른 | Medical devices for tissue sensing and/or stimulation |
WO2017172391A1 (en) * | 2016-03-30 | 2017-10-05 | Dexcom, Inc. | Systems, devices and methods for analyte monitoring system |
CN105828522A (en) * | 2016-05-06 | 2016-08-03 | 鹤山市中富兴业电路有限公司 | Platinum-plated circuit board, and manufacturing technology of the same |
CN106063708B (en) * | 2016-05-24 | 2019-02-15 | 薛迎风 | A kind of intravascular ion transducer and preparation method thereof |
CN106108872A (en) * | 2016-07-06 | 2016-11-16 | 河南驼人医疗器械集团有限公司 | A kind of tremulous pulse thermodilution catheter |
CN109561859A (en) * | 2016-07-18 | 2019-04-02 | 维奥普蒂克斯公司 | Blood oxygen measuring device with laparoscope extension |
US20180235571A1 (en) * | 2016-10-28 | 2018-08-23 | Thomas C. Moore | Device and Method for Intravascular Imaging and Sensing |
CN111132726B (en) | 2017-04-18 | 2023-10-31 | 墨尔本大学 | Intravascular devices for sensing and/or stimulating tissue |
EP3629928A4 (en) * | 2017-06-01 | 2021-03-10 | The University of Tennessee Research Foundation | METHOD AND DEVICE FOR DETECTING THE BIOAVAILABLE DRUG CONCENTRATION IN A LIQUID SAMPLE |
CN107510509A (en) * | 2017-07-10 | 2017-12-26 | 北京万特福医疗器械有限公司 | A kind of microsensor encapsulating structure and its manufacture method |
US10563795B2 (en) * | 2017-08-15 | 2020-02-18 | Newtonoid Technologies, L.L.C. | Flexible poseable sensors and sensor mount systems and methods |
EP3530178A1 (en) * | 2018-02-27 | 2019-08-28 | Koninklijke Philips N.V. | A sensor arrangement for mounting on a guidewire or catheter |
CN108403093B (en) * | 2018-02-27 | 2021-12-14 | 京东方科技集团股份有限公司 | Device for determining the position of a blood vessel and method thereof |
US11185244B2 (en) * | 2018-08-13 | 2021-11-30 | Medtronic Vascular, Inc. | FFR catheter with suspended pressure sensor |
US11415491B2 (en) * | 2018-09-27 | 2022-08-16 | Apple Inc. | Pumping mechanism for gas sensors |
US11478596B2 (en) | 2019-07-18 | 2022-10-25 | Covidien Lp | System and method for high flow oxygen therapy |
US20210275110A1 (en) | 2019-12-30 | 2021-09-09 | RubyElf, LLC | Systems For Synchronizing Different Devices To A Cardiac Cycle And For Generating Pulse Waveforms From Synchronized ECG and PPG Systems |
IT202000010195A1 (en) * | 2020-05-07 | 2021-11-07 | 2Dto3D | INDICATOR SYSTEM FOR THE PRESENCE OF CARBON DIOXIDE IN ENVIRONMENTS WITH A CONTROLLED ATMOSPHERE, ADHESIVE LABEL INCLUDING THIS INDICATOR SYSTEM AND THE RELATIVE SYSTEM PRODUCTION PROCEDURE. |
Citations (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2562544A (en) * | 1948-01-31 | 1951-07-31 | Stromberg Carlson Co | Watertight plug and jack |
US3434869A (en) * | 1964-11-02 | 1969-03-25 | Dow Corning | Foley catheter with silicone rubber coating |
US3494354A (en) * | 1964-09-30 | 1970-02-10 | Tokyo Shibaura Electric Co | Flexible endoscope for use in cancer diagnosis |
US3518982A (en) * | 1968-02-09 | 1970-07-07 | Abcor Inc | Device and method for monitoring of gases in the blood stream |
US3865897A (en) * | 1973-08-03 | 1975-02-11 | Dow Corning | Method of blending polyolefins and polydiorganosiloxane gums and blends thereof |
US3893448A (en) * | 1973-11-26 | 1975-07-08 | John W Brantigan | Catheter device for use in detecting gas in body fluids and tissue |
US3905888A (en) * | 1973-05-10 | 1975-09-16 | Hoffmann La Roche | Electrochemical sensor |
US3926766A (en) * | 1974-11-01 | 1975-12-16 | Gen Electric | Miniature probe containing multifunctional electrochemical sensing electrodes |
US3938502A (en) * | 1972-02-22 | 1976-02-17 | Nicolaas Bom | Apparatus with a catheter for examining hollow organs or bodies with the ultrasonic waves |
US3957613A (en) * | 1974-11-01 | 1976-05-18 | General Electric Company | Miniature probe having multifunctional electrodes for sensing ions and gases |
US4015600A (en) * | 1975-07-07 | 1977-04-05 | Liautaud James P | Catheter needle assembly |
US4016864A (en) * | 1974-08-01 | 1977-04-12 | Airco, Inc. | Blood gas catheter |
US4068659A (en) * | 1976-07-12 | 1978-01-17 | Deseret Pharmaceutical Co., Inc. | Catheter placement assembly |
US4166469A (en) * | 1977-12-13 | 1979-09-04 | Littleford Philip O | Apparatus and method for inserting an electrode |
US4221567A (en) * | 1977-12-23 | 1980-09-09 | Intermountain Health Care | Sampling and determination of diffusible chemical substances |
US4364625A (en) * | 1980-06-12 | 1982-12-21 | Bell Telephone Laboratories, Incorporated | Electrical jack assembly |
US4471786A (en) * | 1981-04-27 | 1984-09-18 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Telemetering intracranial pressure transducer |
US4474183A (en) * | 1983-01-17 | 1984-10-02 | Kuraray Co., Ltd. | Gas sensor |
US4519401A (en) * | 1983-09-20 | 1985-05-28 | Case Western Reserve University | Pressure telemetry implant |
US4573481A (en) * | 1984-06-25 | 1986-03-04 | Huntington Institute Of Applied Research | Implantable electrode array |
US4576181A (en) * | 1984-05-09 | 1986-03-18 | Utah Medical Products | Disposable pressure transducer apparatus for medical use |
US4673584A (en) * | 1982-05-14 | 1987-06-16 | Astra Meditec Ab | Process for providing articles with a biocompatible surface layer |
US4819655A (en) * | 1987-08-04 | 1989-04-11 | Webler William E | Injectateless thermal cardiac output determination method and apparatus |
US4832034A (en) * | 1987-04-09 | 1989-05-23 | Pizziconi Vincent B | Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids |
US4861454A (en) * | 1986-02-04 | 1989-08-29 | Terumo Kabushiki Kaisha | Oxygen sensor |
US4874500A (en) * | 1987-07-15 | 1989-10-17 | Sri International | Microelectrochemical sensor and sensor array |
US4919141A (en) * | 1987-01-03 | 1990-04-24 | Institute fur Diabetestechnologie Gemeinnutzige Forschungs- und Entwicklungsgesellschaft mbH | Implantable electrochemical sensor |
US5007424A (en) * | 1987-08-03 | 1991-04-16 | Hellige Gmbh | Polarographic/amperometric measuring sensor |
US5054882A (en) * | 1990-08-10 | 1991-10-08 | Puritan-Bennett Corporation | Multiple optical fiber event sensor and method of manufacture |
US5070882A (en) * | 1988-03-28 | 1991-12-10 | Telectronics Pacing Systems, Inc. | Probe tip ultrasonic transducers and method of manufacture |
US5165407A (en) * | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
US5240004A (en) * | 1989-04-28 | 1993-08-31 | Thomas Jefferson University | Intravascular, ultrasonic imaging catheters and methods for making same |
US5300032A (en) * | 1988-09-15 | 1994-04-05 | Mallinckrodt Medical, Inc. | Catheter introducer with flexible tip |
US5322063A (en) * | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
US5333609A (en) * | 1992-05-19 | 1994-08-02 | Minnesota Mining And Manufacturing Company | Catheter and probe-catheter assembly |
US5391250A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5409666A (en) * | 1991-08-08 | 1995-04-25 | Minnesota Mining And Manufacturing Company | Sensors and methods for sensing |
US5433205A (en) * | 1994-04-08 | 1995-07-18 | Visveshwara; Nadarasa | Method of optimizing ventilation perfusion match |
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5596988A (en) * | 1993-06-30 | 1997-01-28 | Biomedical Sensors, Ltd. | Multi-parameter sensor apparatus |
US5651767A (en) * | 1994-05-06 | 1997-07-29 | Alfred F. Mann Foundation For Scientific Research | Replaceable catheter system for physiological sensors, stimulating electrodes and/or implantable fluid delivery systems |
US5655529A (en) * | 1994-03-24 | 1997-08-12 | Gold Standard Medical Corp. | Blood gas probe |
US5662960A (en) * | 1995-02-01 | 1997-09-02 | Schneider (Usa) Inc. | Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly (n-vinylpyrrolidone) polymer hydrogel |
US5671736A (en) * | 1995-10-17 | 1997-09-30 | Graphic Controls Corporation | Fetal electrode product with easy-to-handle connector |
US5788647A (en) * | 1997-01-24 | 1998-08-04 | Eggers; Philip E. | Method, system and apparatus for evaluating hemodynamic parameters |
US5804263A (en) * | 1990-10-24 | 1998-09-08 | University Of Florida Research Foundation, Inc. | Combined plasma and gamma radiation polymerization method for modifying surfaces |
US5928155A (en) * | 1997-01-24 | 1999-07-27 | Cardiox Corporation | Cardiac output measurement with metabolizable analyte containing fluid |
US5944695A (en) * | 1997-09-30 | 1999-08-31 | Becton, Dickinson And Company | Multiple sheath catheter using multiple stages and method of use |
US5971934A (en) * | 1996-10-04 | 1999-10-26 | Trustees Of The University Of Pennsylvania | Noninvasive method and apparatus for determining cardiac output |
US5976067A (en) * | 1997-05-28 | 1999-11-02 | Ablation Technologies, Inc. | Combination radioactive and temperature self-regulating thermal seed implant for treating tumors |
US5997517A (en) * | 1997-01-27 | 1999-12-07 | Sts Biopolymers, Inc. | Bonding layers for medical device surface coatings |
US6064900A (en) * | 1992-02-01 | 2000-05-16 | The Victoria University Of Manchester | Monitoring systems |
US6143150A (en) * | 1996-07-03 | 2000-11-07 | Nihon Kohden Corporation | Biological gas sensor |
US6231516B1 (en) * | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
US6248067B1 (en) * | 1999-02-05 | 2001-06-19 | Minimed Inc. | Analyte sensor and holter-type monitor system and method of using the same |
US6254586B1 (en) * | 1998-09-25 | 2001-07-03 | Minimed Inc. | Method and kit for supplying a fluid to a subcutaneous placement site |
US20010029337A1 (en) * | 1997-09-29 | 2001-10-11 | Pantages Anthony J. | Intravascular imaging guidewire |
US6306103B1 (en) * | 2000-01-03 | 2001-10-23 | Sheila L. Tyler | Blood/body fluid collection apparatus and method |
US20010051768A1 (en) * | 1997-10-20 | 2001-12-13 | Joseph H Schulman | Implantable enxzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US20020052563A1 (en) * | 1997-09-03 | 2002-05-02 | Penn Richard D. | Device and method to measure and communicate body parameters |
US6434430B2 (en) * | 1999-03-18 | 2002-08-13 | Medtronic, Inc. | Co-extruded, multi-lumen medical lead |
US6503225B1 (en) * | 1997-12-22 | 2003-01-07 | Celgard Inc. | Device for removal of gas bubbles and dissolved gasses in liquid |
US20030009095A1 (en) * | 2001-05-21 | 2003-01-09 | Skarda James R. | Malleable elongated medical device |
US20030050547A1 (en) * | 2001-09-07 | 2003-03-13 | Lebel Ronald J. | Sensing apparatus and process |
US20030055353A1 (en) * | 2001-09-18 | 2003-03-20 | Keimar Corporation | Apparatus and method for ascertaining cardiac output and other parameters |
US20030078481A1 (en) * | 1999-02-25 | 2003-04-24 | Minimed Inc. | Glucose sensor package system |
US20030105453A1 (en) * | 2001-05-03 | 2003-06-05 | Stewart Mark T. | Porous medical catheter and methods of manufacture |
US20030133835A1 (en) * | 2002-01-16 | 2003-07-17 | Hattler Brack G. | Intravenous oxygenator having an impeller |
US6607477B1 (en) * | 1998-02-16 | 2003-08-19 | Wallace A. Longton | Graduated intraluminal catheter and methods of use thereof |
US20040111141A1 (en) * | 2002-12-06 | 2004-06-10 | Brabec Scott J. | Medical devices incorporating carbon nanotube material and methods of fabricating same |
US20040162472A1 (en) * | 1999-09-28 | 2004-08-19 | Nellcor Puritan Bennett Incorporated | Sensor with signature of data relating to sensor |
US20050003459A1 (en) * | 2002-01-30 | 2005-01-06 | Krutzik Siegfried Richard | Multi-purpose optical analysis disc for conducting assays and related methods for attaching capture agents |
US20050054905A1 (en) * | 2003-09-09 | 2005-03-10 | Corl Paul D. | Apparatus for ascertaining blood characteristics and probe for use therewith |
US20050061315A1 (en) * | 2003-09-18 | 2005-03-24 | Kent Lee | Feedback system and method for sleep disordered breathing therapy |
US20050065572A1 (en) * | 2003-09-18 | 2005-03-24 | Cardiac Pacemakers, Inc. | Diagnosis and/or therapy using blood chemistry/expired gas parameter analysis |
US6965791B1 (en) * | 2003-03-26 | 2005-11-15 | Sorenson Medical, Inc. | Implantable biosensor system, apparatus and method |
US20050272989A1 (en) * | 2004-06-04 | 2005-12-08 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
US20060229511A1 (en) * | 2000-08-31 | 2006-10-12 | Nellcor Puritan Bennett Inc. | Oximeter sensor with digital memory recording sensor data |
US20060235314A1 (en) * | 2003-01-31 | 2006-10-19 | Michele Migliuolo | Medical and surgical devices with an integrated sensor |
US7130700B2 (en) * | 2002-11-19 | 2006-10-31 | Medtronic, Inc. | Multilumen body for an implantable medical device |
US20060243061A1 (en) * | 1999-10-19 | 2006-11-02 | Transonic Systems, Inc. | Method and Apparatus to Determine an Initial Flow Rate in a Conduit |
US20070016381A1 (en) * | 2003-08-22 | 2007-01-18 | Apurv Kamath | Systems and methods for processing analyte sensor data |
US20080041381A1 (en) * | 2006-08-21 | 2008-02-21 | Tham Robert Q | Non-invasive determination of cardiac output, gas exchange and arterial blood gas concentration |
US20080295839A1 (en) * | 2007-06-01 | 2008-12-04 | Habashi Nader M | Ventilator Apparatus and System of Ventilation |
US7491175B2 (en) * | 2002-05-31 | 2009-02-17 | Roche Diagnostics Operations, Inc. | Method and device for measuring blood gas parameters |
US7529574B2 (en) * | 2003-08-14 | 2009-05-05 | Isense Corporation | Method of constructing a biosensor |
US20100010328A1 (en) * | 2008-07-11 | 2010-01-14 | Nguyen Harry D | Probes and sensors for ascertaining blood characteristics and methods and devices for use therewith |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3443869A (en) | 1966-01-12 | 1969-05-13 | Eastman Kodak Co | V-grooved optical system |
US3937502A (en) * | 1974-09-30 | 1976-02-10 | Mobility, Inc. | Dump box assembly |
EP0083969A3 (en) | 1982-01-06 | 1984-08-08 | Novametrix Medical Systems, Inc. | Polarographic gas sensors |
WO1995010975A1 (en) | 1993-10-18 | 1995-04-27 | Washington Research Foundation | Device and method for monitoring and normalizing physiological parameters |
US7343206B2 (en) * | 2003-04-25 | 2008-03-11 | Medtronic, Inc. | Implantable medical lead and system, and method of use thereof |
US20060105453A1 (en) * | 2004-09-09 | 2006-05-18 | Brenan Colin J | Coating process for microfluidic sample arrays |
US20060273061A1 (en) * | 2005-06-06 | 2006-12-07 | Mark Fricke | Method and device for a child resistant dropper closure |
-
2003
- 2003-09-09 US US10/658,926 patent/US7630747B2/en not_active Expired - Fee Related
-
2004
- 2004-09-08 CN CN2004800303973A patent/CN101052343B/en not_active Expired - Fee Related
- 2004-09-08 WO PCT/US2004/029558 patent/WO2005023097A2/en active Application Filing
- 2004-09-08 CA CA002538122A patent/CA2538122A1/en not_active Abandoned
- 2004-09-08 EP EP04783696A patent/EP1662977A4/en not_active Withdrawn
- 2004-09-08 MX MXPA06002733A patent/MXPA06002733A/en active IP Right Grant
- 2004-09-08 JP JP2006526309A patent/JP2007516005A/en active Pending
-
2008
- 2008-02-07 US US12/027,933 patent/US20080125633A1/en not_active Abandoned
- 2008-02-07 US US12/027,902 patent/US20080139909A1/en not_active Abandoned
- 2008-02-07 US US12/027,915 patent/US20080125635A1/en not_active Abandoned
- 2008-02-07 US US12/027,898 patent/US20080146903A1/en not_active Abandoned
- 2008-02-07 US US12/027,905 patent/US20080125632A1/en not_active Abandoned
- 2008-04-10 HK HK08104033.3A patent/HK1113735A1/en not_active IP Right Cessation
Patent Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2562544A (en) * | 1948-01-31 | 1951-07-31 | Stromberg Carlson Co | Watertight plug and jack |
US3494354A (en) * | 1964-09-30 | 1970-02-10 | Tokyo Shibaura Electric Co | Flexible endoscope for use in cancer diagnosis |
US3434869A (en) * | 1964-11-02 | 1969-03-25 | Dow Corning | Foley catheter with silicone rubber coating |
US3518982A (en) * | 1968-02-09 | 1970-07-07 | Abcor Inc | Device and method for monitoring of gases in the blood stream |
US3938502A (en) * | 1972-02-22 | 1976-02-17 | Nicolaas Bom | Apparatus with a catheter for examining hollow organs or bodies with the ultrasonic waves |
US3905888A (en) * | 1973-05-10 | 1975-09-16 | Hoffmann La Roche | Electrochemical sensor |
US3865897A (en) * | 1973-08-03 | 1975-02-11 | Dow Corning | Method of blending polyolefins and polydiorganosiloxane gums and blends thereof |
US3893448A (en) * | 1973-11-26 | 1975-07-08 | John W Brantigan | Catheter device for use in detecting gas in body fluids and tissue |
US4016864A (en) * | 1974-08-01 | 1977-04-12 | Airco, Inc. | Blood gas catheter |
US3926766A (en) * | 1974-11-01 | 1975-12-16 | Gen Electric | Miniature probe containing multifunctional electrochemical sensing electrodes |
US3957613A (en) * | 1974-11-01 | 1976-05-18 | General Electric Company | Miniature probe having multifunctional electrodes for sensing ions and gases |
US4015600A (en) * | 1975-07-07 | 1977-04-05 | Liautaud James P | Catheter needle assembly |
US4068659A (en) * | 1976-07-12 | 1978-01-17 | Deseret Pharmaceutical Co., Inc. | Catheter placement assembly |
US4166469A (en) * | 1977-12-13 | 1979-09-04 | Littleford Philip O | Apparatus and method for inserting an electrode |
US4221567A (en) * | 1977-12-23 | 1980-09-09 | Intermountain Health Care | Sampling and determination of diffusible chemical substances |
US4364625A (en) * | 1980-06-12 | 1982-12-21 | Bell Telephone Laboratories, Incorporated | Electrical jack assembly |
US4471786A (en) * | 1981-04-27 | 1984-09-18 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Telemetering intracranial pressure transducer |
US4673584A (en) * | 1982-05-14 | 1987-06-16 | Astra Meditec Ab | Process for providing articles with a biocompatible surface layer |
US4474183A (en) * | 1983-01-17 | 1984-10-02 | Kuraray Co., Ltd. | Gas sensor |
US4519401A (en) * | 1983-09-20 | 1985-05-28 | Case Western Reserve University | Pressure telemetry implant |
US4576181A (en) * | 1984-05-09 | 1986-03-18 | Utah Medical Products | Disposable pressure transducer apparatus for medical use |
US4573481A (en) * | 1984-06-25 | 1986-03-04 | Huntington Institute Of Applied Research | Implantable electrode array |
US4861454A (en) * | 1986-02-04 | 1989-08-29 | Terumo Kabushiki Kaisha | Oxygen sensor |
US4919141A (en) * | 1987-01-03 | 1990-04-24 | Institute fur Diabetestechnologie Gemeinnutzige Forschungs- und Entwicklungsgesellschaft mbH | Implantable electrochemical sensor |
US4832034A (en) * | 1987-04-09 | 1989-05-23 | Pizziconi Vincent B | Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids |
US4874500A (en) * | 1987-07-15 | 1989-10-17 | Sri International | Microelectrochemical sensor and sensor array |
US5007424A (en) * | 1987-08-03 | 1991-04-16 | Hellige Gmbh | Polarographic/amperometric measuring sensor |
US4819655A (en) * | 1987-08-04 | 1989-04-11 | Webler William E | Injectateless thermal cardiac output determination method and apparatus |
US5070882A (en) * | 1988-03-28 | 1991-12-10 | Telectronics Pacing Systems, Inc. | Probe tip ultrasonic transducers and method of manufacture |
US5300032A (en) * | 1988-09-15 | 1994-04-05 | Mallinckrodt Medical, Inc. | Catheter introducer with flexible tip |
US5240004A (en) * | 1989-04-28 | 1993-08-31 | Thomas Jefferson University | Intravascular, ultrasonic imaging catheters and methods for making same |
US5165407A (en) * | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
US5054882A (en) * | 1990-08-10 | 1991-10-08 | Puritan-Bennett Corporation | Multiple optical fiber event sensor and method of manufacture |
US5804263A (en) * | 1990-10-24 | 1998-09-08 | University Of Florida Research Foundation, Inc. | Combined plasma and gamma radiation polymerization method for modifying surfaces |
US5409666A (en) * | 1991-08-08 | 1995-04-25 | Minnesota Mining And Manufacturing Company | Sensors and methods for sensing |
US5322063A (en) * | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
US6064900A (en) * | 1992-02-01 | 2000-05-16 | The Victoria University Of Manchester | Monitoring systems |
US5333609A (en) * | 1992-05-19 | 1994-08-02 | Minnesota Mining And Manufacturing Company | Catheter and probe-catheter assembly |
US5596988A (en) * | 1993-06-30 | 1997-01-28 | Biomedical Sensors, Ltd. | Multi-parameter sensor apparatus |
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5391250A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5655529A (en) * | 1994-03-24 | 1997-08-12 | Gold Standard Medical Corp. | Blood gas probe |
US5433205A (en) * | 1994-04-08 | 1995-07-18 | Visveshwara; Nadarasa | Method of optimizing ventilation perfusion match |
US5651767A (en) * | 1994-05-06 | 1997-07-29 | Alfred F. Mann Foundation For Scientific Research | Replaceable catheter system for physiological sensors, stimulating electrodes and/or implantable fluid delivery systems |
US5662960A (en) * | 1995-02-01 | 1997-09-02 | Schneider (Usa) Inc. | Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly (n-vinylpyrrolidone) polymer hydrogel |
US5671736A (en) * | 1995-10-17 | 1997-09-30 | Graphic Controls Corporation | Fetal electrode product with easy-to-handle connector |
US6143150A (en) * | 1996-07-03 | 2000-11-07 | Nihon Kohden Corporation | Biological gas sensor |
US5971934A (en) * | 1996-10-04 | 1999-10-26 | Trustees Of The University Of Pennsylvania | Noninvasive method and apparatus for determining cardiac output |
US5928155A (en) * | 1997-01-24 | 1999-07-27 | Cardiox Corporation | Cardiac output measurement with metabolizable analyte containing fluid |
US5788647A (en) * | 1997-01-24 | 1998-08-04 | Eggers; Philip E. | Method, system and apparatus for evaluating hemodynamic parameters |
US5997517A (en) * | 1997-01-27 | 1999-12-07 | Sts Biopolymers, Inc. | Bonding layers for medical device surface coatings |
US5976067A (en) * | 1997-05-28 | 1999-11-02 | Ablation Technologies, Inc. | Combination radioactive and temperature self-regulating thermal seed implant for treating tumors |
US20020052563A1 (en) * | 1997-09-03 | 2002-05-02 | Penn Richard D. | Device and method to measure and communicate body parameters |
US20010029337A1 (en) * | 1997-09-29 | 2001-10-11 | Pantages Anthony J. | Intravascular imaging guidewire |
US5944695A (en) * | 1997-09-30 | 1999-08-31 | Becton, Dickinson And Company | Multiple sheath catheter using multiple stages and method of use |
US6231516B1 (en) * | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
US20010051768A1 (en) * | 1997-10-20 | 2001-12-13 | Joseph H Schulman | Implantable enxzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US6503225B1 (en) * | 1997-12-22 | 2003-01-07 | Celgard Inc. | Device for removal of gas bubbles and dissolved gasses in liquid |
US6607477B1 (en) * | 1998-02-16 | 2003-08-19 | Wallace A. Longton | Graduated intraluminal catheter and methods of use thereof |
US6254586B1 (en) * | 1998-09-25 | 2001-07-03 | Minimed Inc. | Method and kit for supplying a fluid to a subcutaneous placement site |
US6248067B1 (en) * | 1999-02-05 | 2001-06-19 | Minimed Inc. | Analyte sensor and holter-type monitor system and method of using the same |
US20030078481A1 (en) * | 1999-02-25 | 2003-04-24 | Minimed Inc. | Glucose sensor package system |
US6434430B2 (en) * | 1999-03-18 | 2002-08-13 | Medtronic, Inc. | Co-extruded, multi-lumen medical lead |
US20040162472A1 (en) * | 1999-09-28 | 2004-08-19 | Nellcor Puritan Bennett Incorporated | Sensor with signature of data relating to sensor |
US20060243061A1 (en) * | 1999-10-19 | 2006-11-02 | Transonic Systems, Inc. | Method and Apparatus to Determine an Initial Flow Rate in a Conduit |
US6306103B1 (en) * | 2000-01-03 | 2001-10-23 | Sheila L. Tyler | Blood/body fluid collection apparatus and method |
US20060229511A1 (en) * | 2000-08-31 | 2006-10-12 | Nellcor Puritan Bennett Inc. | Oximeter sensor with digital memory recording sensor data |
US20030105453A1 (en) * | 2001-05-03 | 2003-06-05 | Stewart Mark T. | Porous medical catheter and methods of manufacture |
US20030009095A1 (en) * | 2001-05-21 | 2003-01-09 | Skarda James R. | Malleable elongated medical device |
US20030050547A1 (en) * | 2001-09-07 | 2003-03-13 | Lebel Ronald J. | Sensing apparatus and process |
US6616614B2 (en) * | 2001-09-18 | 2003-09-09 | Keimar Corporation | Apparatus and method for ascertaining cardiac output and other parameters |
US20030055353A1 (en) * | 2001-09-18 | 2003-03-20 | Keimar Corporation | Apparatus and method for ascertaining cardiac output and other parameters |
US20030133835A1 (en) * | 2002-01-16 | 2003-07-17 | Hattler Brack G. | Intravenous oxygenator having an impeller |
US20050003459A1 (en) * | 2002-01-30 | 2005-01-06 | Krutzik Siegfried Richard | Multi-purpose optical analysis disc for conducting assays and related methods for attaching capture agents |
US7491175B2 (en) * | 2002-05-31 | 2009-02-17 | Roche Diagnostics Operations, Inc. | Method and device for measuring blood gas parameters |
US7130700B2 (en) * | 2002-11-19 | 2006-10-31 | Medtronic, Inc. | Multilumen body for an implantable medical device |
US20040111141A1 (en) * | 2002-12-06 | 2004-06-10 | Brabec Scott J. | Medical devices incorporating carbon nanotube material and methods of fabricating same |
US20060235314A1 (en) * | 2003-01-31 | 2006-10-19 | Michele Migliuolo | Medical and surgical devices with an integrated sensor |
US6965791B1 (en) * | 2003-03-26 | 2005-11-15 | Sorenson Medical, Inc. | Implantable biosensor system, apparatus and method |
US7529574B2 (en) * | 2003-08-14 | 2009-05-05 | Isense Corporation | Method of constructing a biosensor |
US20070016381A1 (en) * | 2003-08-22 | 2007-01-18 | Apurv Kamath | Systems and methods for processing analyte sensor data |
US20080125632A1 (en) * | 2003-09-09 | 2008-05-29 | Corl Paul D | Sensor probe and display module |
US20080125635A1 (en) * | 2003-09-09 | 2008-05-29 | Corl Paul D | Probe with gas permeable material surrounding a gas sensor assembly |
US20080125633A1 (en) * | 2003-09-09 | 2008-05-29 | Corl Paul D | Probe and display having a gas sensor assembly and surface treatment |
US20080146903A1 (en) * | 2003-09-09 | 2008-06-19 | Corl Paul D | Display and probe having a removable connections |
US20050054905A1 (en) * | 2003-09-09 | 2005-03-10 | Corl Paul D. | Apparatus for ascertaining blood characteristics and probe for use therewith |
US20050061315A1 (en) * | 2003-09-18 | 2005-03-24 | Kent Lee | Feedback system and method for sleep disordered breathing therapy |
US20050065572A1 (en) * | 2003-09-18 | 2005-03-24 | Cardiac Pacemakers, Inc. | Diagnosis and/or therapy using blood chemistry/expired gas parameter analysis |
US20050272989A1 (en) * | 2004-06-04 | 2005-12-08 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
US20080041381A1 (en) * | 2006-08-21 | 2008-02-21 | Tham Robert Q | Non-invasive determination of cardiac output, gas exchange and arterial blood gas concentration |
US20080295839A1 (en) * | 2007-06-01 | 2008-12-04 | Habashi Nader M | Ventilator Apparatus and System of Ventilation |
US20100010328A1 (en) * | 2008-07-11 | 2010-01-14 | Nguyen Harry D | Probes and sensors for ascertaining blood characteristics and methods and devices for use therewith |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050054905A1 (en) * | 2003-09-09 | 2005-03-10 | Corl Paul D. | Apparatus for ascertaining blood characteristics and probe for use therewith |
US20080125635A1 (en) * | 2003-09-09 | 2008-05-29 | Corl Paul D | Probe with gas permeable material surrounding a gas sensor assembly |
US20080125633A1 (en) * | 2003-09-09 | 2008-05-29 | Corl Paul D | Probe and display having a gas sensor assembly and surface treatment |
US20080146903A1 (en) * | 2003-09-09 | 2008-06-19 | Corl Paul D | Display and probe having a removable connections |
US7630747B2 (en) | 2003-09-09 | 2009-12-08 | Keimar, Inc. | Apparatus for ascertaining blood characteristics and probe for use therewith |
US20090209849A1 (en) * | 2007-05-02 | 2009-08-20 | Philip Stephen Rowe | Medical Device Placement and Monitoring System Utilizing Radio Frequency Identification |
US20100010328A1 (en) * | 2008-07-11 | 2010-01-14 | Nguyen Harry D | Probes and sensors for ascertaining blood characteristics and methods and devices for use therewith |
US20100033188A1 (en) * | 2008-08-05 | 2010-02-11 | Rieth Harry T | Apparatus, method and system for determining a physiological condition within a mammal |
US20100057046A1 (en) * | 2008-09-03 | 2010-03-04 | Keimar, Inc | Systems for characterizing physiologic parameters and methods for use therewith |
US20100204556A1 (en) * | 2009-02-12 | 2010-08-12 | Keimar, Inc. | Physiological parameter sensors |
US11504517B2 (en) | 2015-12-11 | 2022-11-22 | Nxstage Medical, Inc. | Fluid line connector devices methods and systems |
US20170167186A1 (en) * | 2015-12-15 | 2017-06-15 | Sage Electrochromics, Inc. | Insulated glazing units and electrical feed throughs |
US10253549B2 (en) * | 2015-12-15 | 2019-04-09 | Sage Electrochromics, Inc. | Insulated glazing units and electrical feed throughs |
Also Published As
Publication number | Publication date |
---|---|
JP2007516005A (en) | 2007-06-21 |
HK1113735A1 (en) | 2008-10-17 |
US20080125632A1 (en) | 2008-05-29 |
EP1662977A4 (en) | 2008-01-23 |
US20080125635A1 (en) | 2008-05-29 |
US20080125633A1 (en) | 2008-05-29 |
CA2538122A1 (en) | 2005-03-17 |
MXPA06002733A (en) | 2007-04-09 |
CN101052343B (en) | 2010-04-07 |
WO2005023097A3 (en) | 2007-06-21 |
WO2005023097A2 (en) | 2005-03-17 |
EP1662977A2 (en) | 2006-06-07 |
US20080146903A1 (en) | 2008-06-19 |
CN101052343A (en) | 2007-10-10 |
US20050054905A1 (en) | 2005-03-10 |
US7630747B2 (en) | 2009-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7630747B2 (en) | Apparatus for ascertaining blood characteristics and probe for use therewith | |
US20100010328A1 (en) | Probes and sensors for ascertaining blood characteristics and methods and devices for use therewith | |
JP5802665B2 (en) | In vivo sensor assembly | |
US20100057046A1 (en) | Systems for characterizing physiologic parameters and methods for use therewith | |
JP6088064B2 (en) | Method and system for optimizing sensor function by applying voltage | |
US20100204605A1 (en) | Physiological parameter sensors | |
US20110184258A1 (en) | Balloon Catheter Analyte Measurement Sensors and Methods for Using the Same | |
Gottrup et al. | Continuous direct tissue oxygen tension measurement by a new method using an implantable silastic tonometer and oxygen polarography | |
JP2002536038A (en) | Holter monitor system with analyte sensor | |
AU2003225823B2 (en) | Apparatus and method for ascertaining cardiac output and other parameters | |
Zhou et al. | Biomedical sensor, device and measurement systems | |
Mendelson | Biomedical sensors | |
WO2011062683A1 (en) | Systems for intravascular measurement | |
Venkatesh et al. | Continuous measurement of blood gases using a combined electrochemical and spectrophotometric sensor | |
US4512349A (en) | Method of direct tissue gas tension measurement and apparatus therefor | |
Eberhard | Continuous oxygen monitoring of newborns by skin sensors | |
US20040010185A1 (en) | Method for measuring a physiologic parameter using a preferred site | |
Podlepetskii et al. | Microelectronic transducers and converters for noninvasive monitoring of the functional systems of humans | |
Brown et al. | Clinical Evaluation of three Types of Continuously Measuring Oxygen Sensors—Their Potential Use for Computer Control of Blood Oxygenation | |
JP2009207924A (en) | Device and method for measuring cardiac output |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KNOBBE, MARTENS, OLSON & BEAR, LLP, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:KEIMAR, INC.;REEL/FRAME:025309/0123 Effective date: 20101027 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |